Вы находитесь на странице: 1из 197

PROCEEDING

“The 2nd International Conference on

Pharmacy and Advanced Pharmaceutical Sciences”

Book II : Clinical and Social Pharmacy


First edition, November 2011

Project Editor: Triana Hertiani


Designers: Puma Arfah and Firman Romansjah

Copyright © 2011 Faculty of Pharmacy

Published by:
Faculty of Pharmacy Universitas Gadjah Mada
Sekip Utara, Yogyakarta, 55281,
Indonesia

Editor : Ronny Martien


: Zullies Ikawati
Editor in Chief : Triana Hertiani
ISBN : 978-979-95555-9-5

All right reserved


No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any
means, electronic, mechanical, photocopying, reccording or otherwise, without the prior permission of the
copyright owner

Printed by:
PASS OFFSET
Jl. Lowanu 23
Yogyakarta - Indonesia
Preface from the Editor

! "# " $% & $ $


% $

% & ' ( ) * + &


, % - - .)
/0 $ % & 1 23 & 2
( ) * + $ 2
& 4 & &
& 2" $5
' &

& 6 ( ) * + ,
% # - - .) /0
& 7 7 5 &
$7 & 0
5 ' &
$
7 &
$

# "

-$ $ $% 8 +$ $ $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences i


Organizing Commitee

Steering Committee
$- $+ -/ $ $9 ()+ :
$- $ ; +$ $ $9 ()+ :
$- $/ + +$ $ $9 ()+ :
-$ < , +$ $ $9 ()+ :
$ - $ -* ; $9 ()+ :
$- $= & $9 ()+ :
$- $ 9% :
$+ < & $ -$ 9, % # :
Chairman
-$ $ $% 8 +$ $ $
Secretary
-$ $ $6 + +$ $
-$ $ $6 $/ > +$ $ $
Treasure
$+

ii The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Welcome to Yogyakarta,

- > )
5 5 ' &

" $

% ' ( ) * + & ,
% - - .)
/0 $ % 1 23 & 2
( ) * + $ ?
& 4 & &
& 2" $8 & &
& 0 *
& 0 $

% 5 ' & 6 ( ) * + ,
% # - - .) /0
. & 7 7 5 &
$7 & 0
5 ' & $

7 & *

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences iii
Remarks of the Dean of Faculty

@ & $& $
- A $
7 7 ( ) * + & &

$ & $

>
% ' 7 ()+ & ,
% 9, %: # - - ) 23
7 ()+ 2 ( ) * + $ &
B $
& $

& & * &


$ & 0
$
% & & &
& & & *
$
7 & &
$

&
Wassalamu’alaikum warahmatullahi wabarakatuh,
+
- 7 ()+

iv The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Opening Remarks by Rector of Universitas Gadjah Mada

$ $ * & +$ / $ $-
C
1 & &
C $- $/

-
) $ 1 & %
& DC
E ' & - - ,
% # 23 7 ()+$ %
$ 0
&
& $%
F 1 &
$+
&
& & $
& & & &
$ & &
&& & &
$ & &
$ & * & # * $>
& $

% $
; 1 & & $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences v


! " #

$ !

% & "
232

% ' ( ! ) ' *

456

+ ' ) '! " )

7 5 48

, ' - ' ) ' ! (

44 5 47

! ' !. , ' . * / ' 0 ( '


( * '! ( ' # ( ,

49 5 4:
( ' % + '

! ! ;8 5 ;7

' '1 )

" ;9 5 <=

' '1 )

<6 5 <9

% + ' ( '

<> 5 ==
* '1 ' & " '0
=6 5 6;

" !. * ( '* . & ' . " ' * '? .


+ "

6< 5 6:
!
'! ' ' 0 "

# 785 79
$ %
! !
0 * ' @ + (' @ + A ', B' ! ' ,+ '% -

" 7> 5 9;
&
. ( *' * 3 ' "

" 9< 5 97
' ) ' ' ' *

# ' 99 5 >;
, '

>< 5 >:
! ! !
,. ' A @.+' .!.' + .,.' . .' + .,.' - %

" :8 5 :=
' ) ' ' ' *

:6 5 48<

1 ) ' " ! ( '0 ',

48= 5 489
$ , . ' . 3% .' & ' '

48> 5 44;
! " ' + ' " " ('

44< 5 446
(

! " ' #) " ' # (

# 4475 4;9
) &
"' #) " ' # (

" * ! 4;> 5 4<6


! $ %

# " ( ' ( #( & '@ 3 /


4<7 3 4<:

. . ( *' , ' ( ' 0


2 )

$ % + 4=8 3 47;

! '

47< 3 49=
& (,-,
! ' # ('# "% ( '

% , !# 1 * ! 496

% , !# # C 499

# 1 49>
Nyoman Kertia et al.

! "

# $ %&'(
) * + !
&' # +
$ )
+ ) ) +
* $ '
, + *+ ) -. ) $
+ // % (
-.. - 0 1 % ( )
) + ) ) &' ! ) )
2
! * 3 ) 4 *
) , + # ) , #
* ) ) *
' 56 ) &' ) # )
$ ) 2 78 856 96 ) ) ! 2 7: 78- 5-
1 # + '
$ ) . 68 * $ ) 2
78 856 96; . 68 < 2 -9/ 7:: 5: # ' +
1 ) . =7 *
) 2 7: 78- 5-; . =7 < 2 5- 97. =/ *
6) ! ) 2 5 5.6 ./ ) + *
+ 1 #
&' ) ) ! + // -.. -
1 ) ) + * -. )
$
; 0 * > 4 $ > 0 + 0 1
>&

!" #
& %&'( ) , +
)
+ ) , $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science ix


Cost-Effectiveness Between............

& 3 +
+ ? $
# &' + +
-

4 $ * * %@ ' (
# 0&A
6:
+ 1 + + $ #
@ ' !
7
@ ' :. ) &' ) $
9 ) 5.B
$ ) +
+ ) '
5
$ :. ) :-*8. 0 %
( + + +
' + + $
8
% * $ ( $ $
C $ &'
) # $
+ + #
* +
1 $ &'

$% !#
&" '$ %
+ ) ) ! &' )
2 !
! &'> ) $ &' + D 3
%E /( & ) + ' 0 2
) ) C$
&' >
+ + ) F6 G $
@ '

$&$ $% !#
# ) , + *+ ' + )
$ $
) + &'
&' $
+ * -% (
) ! 0 &' $ %D 3 $(
3 ) &' ) + '
%' (9
+ ) ) 4
! ) & 4 $ %
-. $ ( % //

x The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Nyoman Kertia et al.

-.. - 1 ( ' ) ) !
+ ) # ) ! ) * )
+ + + $ # )
) ) ! ) + #
+ + C 0 H 2

&% %(&%( ) )*&(&


# $
+ 1 ) ,
+ ) , + * 3 4 *
) , + D ) E. .5
) /5B # ) ,
# * ) ) *

$&")%
) &' ) #) $ +
= + + + +
+ + $
+ 6 ! @ ' $ - + !
- + ) + ) - + )
# + ) 79 ) 6- 68 )
87 59 I 9 9: % ) :9 ) =6 (
) -. := I : /: &' ) 5- 7: I
76 -: + ) ! &' ) := + ! &' ) 8
+ &' : + D 3 $) 5 65 I 6 75
79 + := + ) 5 + )
7 + ) !
4 $ ) + % E . .-( ) +
1 ) + %
<. .6( ) % E . .-(
+ $ ) -
! ) + 1 0
+ $ +
- + +
# ) 2 78 856 96 ) $ ) ) !
1 2 7: 78- 5- #
' $ ) . 68 * $ ) 2
78 856 96 ; . 68 < 2 -9/ 7:: 5: # '
+ 1 ) . =7 *
) 2 7: 78- 5-; . =7 < 2 5- 97. =/ *
+ 1
$ 6) ! ) 5 5.6 ./ ) + +
1

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science xi


Cost-Effectiveness Between............

#(& "&&(!
# ) , + *+ )
0 + * + +
' &' %-: 5B
-.B ( + 6/ -B + 6: 5B
=

# ) *
+ ) )
*

/
+ *
0 +
! * * ) / 8B )
$ * %6.B(
# + + 1
) + $ H
) ) + '
* )
-.
* $ * $ *
+ >
! * +
&'-- )
) $ ) + &' +
+ &' 0
+
-6
) ) ) H 0 *
4 % ( $ 6.B 7.B
7.B @ ' #
+ -... $ % ) 6.. (
' = &' + /: #

#
* &'-:
2 )
+ $
-7
) &' )
) + +
+
1 $ '
$ ! @
+ ) ! + + )
) ! +
+ ) !

xii The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Nyoman Kertia et al.

# ) 4 -
-. ) $
2 :-9 =5 # //
-.. - ) 2 7-= .. # )
) %- + : : ( %- + 6
: ( 4 - + ) 2 :8 .. - +
) 2 -:: 5. # ) ) +
+ $ $ ) 2
6 5.. .. D + $ 2 -8 7.. ..
)
3 + ' 3
) &' ) ' 3 # *
. 86 . /7 %/-B . 85( )
* ) . 8: . /6 %=6B . 85(
2 + ) ) ) % (+
! *
! ) )
2 0 ) )
D! ) + )
+ :.

! )"&(!
+
+ 1 )
) $ # )
+ ) !+ ) $ +
1 0 *
&' + + //
-.. - 1 ) ) 2 5- 97. /= # ) +
-. $ ) ) ) ! ) ) 2 -9/ 7:: 5: )
* 2 5 5.6 ./

&" $&%(!
+ 1 + *
$ +
1 )
'

$+$ $ $&
$ H ' 6..9
6%7( 5//*8.7

4 H + 0 6..5 0&A*6 + *D :56;--*


-9

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science xiii
Cost-Effectiveness Between............

H DD D , J 4 ! K D 6..8
-- ) @ ) !

D 6..= & ;# K J J 0 D J L 4
% ( ! " # -: 6:5*7. ' @ )
!
# -//5 @ ) 4 ' * 4 % (
$# -*-6 ' !

J H M ! D ! H 2 6..7 H 4 0 0
' ! % & 77;/9*---
' ' -//7 C! K H 4 ! D 2 4
' ( ' ( "& % ( ( (
)* +!&) " & , ! -5.*-57

K D ! 2 # 0# ! ' K ) -//8
! 2 ! ! & - (
. H )

D ) J 2 D) K -//. / $ & & 0 &


J L N @ ) !
! J D & , J @ J H 0 D , 2 0 J O '
# H @ 6..8 # C$ 0 0 4 C$
2 ' 8/%:(; :5-"55
' 2 # M ' -//5 $
2 ' 7%' ! ( 0 &$
$ !

0 @ 6..: ' * ' 0 ; ' 0


# % ( /%-(;-8-*8=
H 0 2 4 D D ' #
' 6.-. C 0 * 0 $
C$ ' & 4 ! 1 6- 6.-.
; -5 7

2 4 ' ' K @ -//8 K ! H ' 4 4 ! !


+ ! K + K ! ! ' K ! 4
& %4 4 ( ' ( $ (
" 2 4

xiv The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Amelia Lorensia et al.

!
"#$ %& ' ( ) ! %*
! +,- ! %.
- !
!
! /
!
(, 0 !1 2
3 - 4 !1
! /
!
! 5. -
6&7 !
! 89 65* ( ! ! ! :6 ! -
! 79 .;*
% 7<* - !1 !
!
! / !1

= !1

!"
#
! !
1 ! !
$
>
%
! ! "#$ 0"
# $! / 2 %& ' 1 0( ) 2
#
! %* ! +,- 0
+ , - !! 2 ! %.
%795 +,- ?$ ( 0
2 4 & %. +,-@ %776
?$ ( 8 ! 0 2 " %77&
%<A%... ! %%A%... 6A%... & -
B C ! 0B C 2

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 1


Study of drug-selection……….

/ !
#
! !
!
4&
- !
!
! /

C4
- !# !
/ ! ! %.. 0
! 05.2 ! 08.22
1
'

-
! ' ! !1
(
! -
! ! 0 !
A (, 2 ) (,
: 06..;2 ' (,
, (, 06<*2
' ! 0%%*2
0;*2 ! ! '
)
(, 0D8.*2 !
*
(,
3 -
!1
+
0(, 2 ! !
#, ##
!1
(
!1
! $ / ! !1
! !3
#$

- 4 !1
/

- . /0
-

123 1 3 4 5
( ! = !1
=
!

2 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Amelia Lorensia et al.

6 7 1 7
- / # "
# B 6..9 B 6.%. /
! # " # B 6..9 B
6.%.

1 3 31
!

8! 8"!88
5. - 66
0<5 5;*2 <9 05< <<*2 !
! 6. ' ! 96 $ 5.
8& 88* %%16. E 66 ;<* 6. E 66 ;<*
61& 8 &&* 51%. 8 && *
/ !
! !
4 !
# #%

5 #9 1 7 2 :8 31 6 5 8 7 1 " 3 1

:8 31 6 5 7 3 0*2

! %6& . %6& 89 65
0 1 2

B ! 9 . 9 < .7
& &8 &7 66 ;9
! !
6& . 6& 7 5&
!
!
!1 6 . 6 . ;;

- ! 6 . 6 . ;;

F 1 ! < . < % %5

! A ! %; . %; 5 &5
3 !
B ! %9 . %9 5 7&

$,' '& $'+

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 3


Study of drug-selection……….

( ! ! ! !1 ' -
- A
! " 4 :6
! - A
#
!1
- !
=
% ! 0 2
> > 06..72
6 +C 1 =
? !
, ! / ! ! !
, ! / G
, ! / ! !!
B

" " !8
-
! ! 0
F, A F , 2 F ! !
/ !1 A A '
4 !

; "
> > ! F ! H 0 2
6..7
/F I F ! F JF F + + 1 4 C
: ! +? =
J? 6..%E 8%= 5591;5
B C ! > !
! = C' , 6 B # =B
# ! : %77;
F ! # " + ( )
( ! 4 = ( 4
6..8
C > C # 1:
? 6..9 J 1F E50%2=6&1<6
: ! : ? ? F FJ F 1? FJ ? =
? 6..8 ( 8E%.0<%2=<7<%185
+: /1 : =
6..&E<7=&<718%

4 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Amelia Lorensia et al.

: ( ! , F F ? "
# $! / =C F ( 0C(F2=
? ! F 0 ? F2 K L 6..; K 6.%. J
6%L
# 1 # > / F
? J# 1 %775E&<= %;%<M5
? , + " + 1+ F ) ! ) > ! :J ! :+
- ? = + 1+ F ) ! ) + "
> ! :J ? , - =- ? ( ! 9
" H" 4 E 6..&=% %1% 6%
F I ( !1 = ? ? J F
? ! K L 6..&E%.
, = =AA !A A A%.16 4 %8 $4 6..;
: '# I 4 + , - F : # - F #
# ( !1, = , > #
C J ? ! K L 6..8 K 6.%. ( %8LE5.072
, = =AA ! 4 A A !! 3'.; 6' 'A
F ! # 4 B ? E 6..5

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 5


Ana Yuda et al.

!
"# $%
# &
'
( ) *+,,
-+ -+
$ .+ "*. ,/%
# $
0 .+ "1 */%

*+/ ",12.+%
34 5 3/ ( 1* 6/
,* 3/ *+
7 7

&

!"
89 &
") : *++6% ; <90 "*+,,% *++4 ! 1*3 1*3
89 ) : "*++6%
) 9 89 #
# # !

89 "8 = *++6% #

0
"# $%

6 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


The profile of community pharmacies.............

"8 ,---% :
# "# $%

# $ % &

& '
( )
*+,, -+
>
-
-
-
-

#
# *+
" * ,%

>
, (
*
5
1 " %

3
4 # 7 & 7
&
. # 7 & 7 ? ?
? ?
6 7
" %

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 7


Ana Yuda et al.

34
' 2
# ) @
A! 7
2 * 7
7 2 B

$ 9

0 @
@
2

A "C
D ) 7 % #
# A E 8 "#7 7 # %

'!% ' '"!'' '


-+ # ( *+
"** */% # C $
A
89 # &

*+ "56 3/%
7 &

!
7
# "0 8% &
#
" A DA '# *++4%
0 .+ "1 */%

'
!

*+/ ",12.+% 34 5 3/ (
1* 6/ ,* 3/ ;
) 9 # $ ,+*. *++1

8 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


The profile of community pharmacies.............

*, 7
7
( !

( )( *

$ $ & /

, -+ *+ ** *
* 7 .+ *+ *6 3

5 F .+ 5 1*

1 F .+ , ,1
1 F .+ , ,1
3 C >
< .+ ,1 *+ +
< 34 *1 1* 6
< ( 34 . ,* 3
34 * 53
. > .+ *, 5+ +
*, 5 ,1 *
< *, 4 *6 3
< *, * -3
< *, , 1.
< ( *, 1 ,- +

" "%!'
&

" % & #
:
F

+ " '
7 *++4 B ' # > )
A "A % # , ' - E 7 >C 7
A7 ,**@,14
8 *++6 # 9 > 8 @; ) < ;F
C ) ) D E) ' E8 E "A %

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 9


Ana Yuda et al.

, . ( , .( / , . . > ) F @9 8 #
,+,
8 ) ' ,--- ) A ' >8 ) ' "A %
# . >
D ' 7 # *++1 ( 0
12345# '5' 5 653227 ) ' , * ( 0
E 7 > D ' 7#
D ' 7# *++4 , , )) 8 9 8
9 8 8 E 7 7 ; D 7 : ; D
D D ' 7#
D ' 7# *++- , * 322: E 7 >
D ' 7#
A 9 ,--4 > C E "A % ) ! " . " ' *
, . * C > *3@13
9 ) 8 ) *++4 B
9 B > ) A "A % #
, ' - E 7 >C 7 A7
16@4-
C D C ,--. ' ( ' ; $ '
, . . # F > <90
< )8 7 E' ; 8) 8 < 7 8) F E) ) E
*++1 8 , '.
$ >D *4 5*@5.
< )8 $ F F *++4 '
' < * , .
, . . ,1 65@-5

10 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Anita Purnamayanti Rahman et al.

! " !!
# !

$ !
" !! % & '
$ % $$( (" ) '

*
+ ,
( - * ! ,
!
! (- '
* * .
( - . / 0 .
( 0
+ 1 (! 0
! 2( ! 0 0
( - 3 * . 4
!
5 6 7 7
& ! 1899:2( - 0 *
* ! ! , (-
0 , 0 ( )
. ; 4
5 (-
! (
" 4 0

# $ %!&'$#%
- !
! + ! (
! , !
! (

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 11


Pharmacoeconomics study as a.............

< 1 2 *
8
(
- ' 0 0
8=>
0 , (
- 8( - (=

- +
! ($
1 !( ! 2( $
1 !(
8>
2
! 1 !
2( ! ! 5
< (8
" ' !
! * ! ($ !
'
(- > ?@
=
! (

! ! (
8
- A * !
# ! (
! !
! !
(

($ %!%)%
- * ! ,
! !
(- ' * *
. (-

12 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Anita Purnamayanti Rahman et al.

. / 0 .
(
- 3 * . 4
!
5 6 7 7 &
! 1899:2(8 - 0 *
* ! ! , (- 0
, 0 ( *
, ! (

(*&)$* ! !#*'&**#% *
) . ; 4
5 (
) 6
!( . * *
> '
(
* (

!
8
! ( - .

- =( - % % *
- 8 - =
#
B < 5 * C D D

$ + 5 D D
! C
+ ,
B * C1 D D
! 2
(-- ,
B 5 ! * D D
* C

- ! , * E E
!
C
- 8 - =
. ,
$ D D
C

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 13


Pharmacoeconomics study as a.............

B C D D

B C D D

B C

1* 2 0 !
C
' /!
B < D D
C

B < D D
C

- 8 - =
' !
B C
& ** C D D

B < C D D

B C

B < *
C

B ' C D D

B < D D
C

- 8 - =
' !
B 1 2 !
*

! C
( .
& C D D
1 0 0 0 0
, 0 2 0 0

14 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Anita Purnamayanti Rahman et al.

0 0

* , .
B *
< C

* *
! ' C

- 8 - =
* , .
$ !
C
! 0' .
$ 0 D D
C

B D D
* . C

B 0 D D
< C

B C D D

B * D D
C

- 8 - =
! 0' .
$ ! , C D D

$ C D D

'% ')&*#%
" . !
(
& * ! ! 6
# (

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 15


Pharmacoeconomics study as a.............

'" % )(! ( ( $

( ( ( '(*
8( " A %) " "- F ! F =GG= E ! (
( =1>2(
=( # % =GG: " - ! & , 4
B % C( ( :H1 H2(
>30H:(
>( F $" & I( $ =GG: 7 & 4 "
% * % , - (
(

16 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science


Ayuni Nazihah Awaludin et al.

! " #
$ % & ! ' $
# ! ' !
( ) $* !+
! ' #
! ' ! $ ,
- & % . / &
- ! $ & 01
- $ & ( & # #
& !
' $
- & $ 211
$ 314 # # #
" # $ ,! 564 $
714 # # !
$ 814 !
! $ + # !
$ ( & #
# $ ! '
# $ #
$
!

! " #
$ , "
!
$ ( & !
$9 % & ! '
$ # ! '
! ( )
$
* !+ :
9$ ! ' $
0$ # ! ' ! $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 17


Pharmacists in the eye of.............

! " #$
- & % . / &
- ! $
& # # & !
$ & &
$

& 01 - $
& ( & # # & !
'
$ - &
$

, & & ; ( # ; ; <; ;; 95$1


# = >$ & ? $

!% % % %% %
211 $ 824 < @9A1> &
894 < @932> & # $ ,! &
01 26 # <68$54> & 80$54 $

( & # #
$ ! ! & ( & #
! & # $0
= 514 &
& # #
# $2

902
& & !
& ' ! # $

* & ! $= &
& & $
* ! # ? ?

%
! ' # $
! & $
# $

! #! !
B & ( ( * !$ , % .
/ # $

18 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ayuni Nazihah Awaludin et al.

!&! ! !%
? ( $,$ .$/$ $/$ C ? D$ B # $B$ 0191 E =
% ; : C ! #
0191$
B ! .$ ; ;$F$ F$ 0191
# # G $
, 7 35)A2$
= /$ D$ / $ $ $ 0119 , # !
" # :, 93 627 628$

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 19


Azza Faturrohmah et al.

!
!

" !
" # $
%
& '
!
% " ()
% * +,-
. !

! ! %
/ 0) ),1 !
% / 0) ),1 * %

% / 0) ),1 "
! !
" 2 3

"

% ! &
% !
!
5 .
%
! /6 78891
"

20 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Performance of community................

! !

/ # :)),1 " !

" ! !
! $ '
# /; 78(,< = 5 788+< = . 788>1 "
$
? ' ! . ! . !
!
" # $
%

! " #$

& '
! " !
" ! !
,98 ' ! @@
A) >:< BA) ),< A) 7 !
/C ! 788@1 %
5
= D :))+

% &'
"
$ " '
! . ! . ! ! "
! %

! . !
" !
@& C. & 7/ 1 @/ ! 1
5
= D " ! .
/ :))81 E
! ' ! @&
C. & 7/ $ 1 @/ $ 1

( '
!
77 , C ! '

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 21


Azza Faturrohmah et al.

) " ) ) )) )
E ! . !
! ! E >)) . 7)-
! . F ! 8@ !
() ! ' / A
(: +@1
" 7 " /G 1
!
+7 99G7) (8 ()- ! ! % $
! /G 1! 7+ 87G7) )7 E $
! /G 1 ! . ! 77 (,G8 8@
! >@ ,- #

* +,- . !

/" :1
"
! !
@9- ((- %
C .
! ?D* /? D
* ' 1 /:)):1 ! ! ,)-
! ,)- . ?
.
! ' /6 78891
$

/ 788@<
?D* :)):1
E ! %
" > !
&
$
! ! !
/ 0) ),1 "
$ " + & '
! . ! . ! !
E !
! % / 0) ),1 =
/ *H 1 ! '
! %
/ 0) ),1
%

/ 0) ),1

22 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Performance of community................

" ! !
!

I ! !
! .
/J :))(1 &
$ "
% ' .
$ % D

! ! /J '
:))+1 " ! 4
#
! / :))@1 5
. %
/?D* 788+1

" )
"
! !
" 2 3

" )
! & !
! % !
!
'

*" #
E
#

)
# :)), 5 % =
K 6 , 5
5 < =
5 :))@ L ; C 4 " . E D
H 7+478> 4
4MM . M M -:) -:) ! .M D5C+@:N
-:) .
# :))8 * '
5 98
5 :))8 >&( " .

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 23


Azza Faturrohmah et al.

788@ F 4
4MM!!! M!!!M M N O A:97P N A
; 6C 6 6 = 78(, * ' L
4L
= D :))+ 7):@M= . M QM RM:))+
5
6 = D 7889 5 5 5 = =K
5 C >>8&>,)
C ! D ? Q 6 C! Q 788@ ' D
; # =
= 5 E 5 6 5 . E 788+ 5 " =
6 @8 /+1 4+8>&,),
= . = 788> ? . ; 4 L . M5
5
? D * ' 788+ " E " 5
= ; 4
4MM ! M M
M! ' >: M! ' >:
? D * ' :)): E = 45 5
?D* = ; 4
4MM ! M M M >)77 M >)77
J ? :))( H C 4 E
:(/7:147+>@&7++: 4
4MM!!! M M M MJ 55 7)&)@
J ' :))+ C . D & 6
D & :))+< 974:,9:&@+ 4
4MM!!! . M N M= Q M= Q M M N
N7: )+

24 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Performance of community................

&' 5, / 6 ( - . ( ' . ) 0 6 ( (
1(7893
% '
/ 1 G +7 99 G 7) (8
-? ()
-= :)
G 7+ 87 G 7) )7
! . G 77 (, G 8 8@
? . -
9: ,)
S >@ ,)
-
= ! >: ,)
= 9@ ,)
? .! -
* @ ,)
" 8( @,
5 . 7))
G , ,, G + +(
! . ! . G :@ ,9 G :: 7,
G ( )> G ( 78
G 7, (@ G 7> >9
T= $ ' / 1
T A

&' +, - .' .- . ( ( / (. ( ( '' (/ ( ( (/


) 0
- . ( ( 123
0
!/ "
(. (
4; ! ,@ /@71 :> /:81
-; ,9 /@)1 :+ />)1
-; +@ /,81 >> /+71

( '' (/
-; ! +, /,91 >, /++1

-; ! >) />(1 ,) /9:1


( (/
- . ! 78 /:+1 97 /@91

-= ! 7) /7:1 @) /((1

0 '' ++ /,,1 >9 /+,1

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 25


Azza Faturrohmah et al.

&' :, ( . ( 0 ' . / (. ( ( '' (/


( ( (/ 6 . ( .6
( 0 ' (;)
= 9 )+G) 8>+ ) +(,
" , :(G7 ,,7 ) )+>
C , ((G7 )(+ ) ))7
K$ , 99G) 8,+ ) >(7

&' <, ( . / ( ( ' . / (. (


( '' (/ ( ( (/ 6 . ( .6
/ ( ( ' (;)
? . , ,>G7 7>9 ) @>8
? . 9 ):G) ((7 ) +:8
E ! , 9)G7 7@9 ) ))@
C ! 9 >7G) (), ) 8@(

Table 5. Result of F-test (simultan regression) for individual and organizational factors to
drug information, counselling, and monitoring performance

% 1&3

= =
7 E +> @++ ( , +9( + )+: ))7/ 1
E 89 ),9 @7 7 >,>
" 7>8 ()) @8
4 /5 1 C ! " ? . K$ ? . =
E ! C
H 4

26 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Azza Faturrohmah et al.

! "
# $%&%'
(
!) * *

* * ! "

!" + ,
! -
. *
,
!" /% , *
!0 1$!23 (
!
, 4 5%!%26!
, 4 5%!%26! "

! ,
! !
"
! # '

!
7

! "
# $%&%'
(
!) * *

* * ! "

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 27


Community pharmacists’ performance................

4 ) $%%8 6!

(
49 0 &::86! (
4; &::<6!
=

4 + $%%26! " !
"
* ! .
+ 4> ! &:/2? ) @ ! &::8? ) ( &::A6! "

! 9 . ( (
!
" + ,
!

!" # $ %&

- . *
! "
!"
2<: ! . 11
B%!A$? CB%!%2? B%!&
* 4D ! &::16! ,
@
) $%%8!

' ()
"
! " .
( ( ! "
,
!

!
(
!"
1- D( - &4 6
14 6!
@ ) !"

28 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Azza Faturrohmah et al.

( 4 ! $%%:6!
E .
1- D( - &4 6
14 6!

* ) !
*
&&!2! D .
!

" $
E ( *
!E A%% ( &%3
( !F :1
* /% * . 4 B
/$!816!
" & !" 4G 6

8&!<<G&%!/: /%3 ! ,
4G 6 &8!:&G&%!%& !E
4G 6 ( &&!/2G:!:1
! A1!23 +
! E
1&!A%3 /A!/%3 !
" $
!
2%3! 1$!23 (
!" ,
! "
(
- - 4 ! !

6 4
H- I 6 !" (

J .
49 0 &::A6!
E ,
!" A
-
!
4 5%!%26! "

! " 8 - .
( (

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 29


Community pharmacists’ performance................

! = .
, 4 K%!%26!

4 5%!%26 4" 26!


) 4 =0H 6
,
4 5%!%26 . 4 K%!%26 4" <
16! .
,
4 5%!%26!
"
!

L
(
4M $%%/6! - *
! "
, . (
, !

4M .
$%%86! " * 7
+
4 ! $%%16! @
( ,
49 0 &::86!

$
"
! ,
!
!"
! # '
*
, !

$!
-
,
!
* ! .
!

+$" %"!"
! ! ! E !

30 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Azza Faturrohmah et al.

! + ! !

" , " "


.. ! ! )! ! !J 7 .. . %8N !

" " " "


+ ! $%%2 @ , )
J ; ! 2 @
@ ? )
@! ! $%%1 O > D 7 " ( E *
H !&87&:A! 7
7II !( ! ! I * I 3$% 3$% (I @D81$P
3$% ( !
! + ! $%%: 0 .
@ ! <:
@ $%%: A-/! " ( !
> ;!D! ;! ;!)! &:/2 0 . O !
7O
) $%%8 = !
) $%%8 = &%$1I) ( I QI RI$%%8!
@ !
; )! ! &::< @ @ @ !)! )!J!
@ D AA:-A2%
D ! !9! Q ;! D !Q! &::1 .
!> + )
) @ E! ! @ ;! ! @ ( E! ! &::8 @ " )
!; ! 1: 486 78:A-2%2
) ( !)! &::A 9 (! > 7 O ( I@
@
9 0 . &::A " E " @ E
9 0) " ( ; A& SA &::A! 7
7II ! ! I I I $::2 I $::2 !
9 0 . &::8 " E " @
) !> ! 7
7II ! ! I I . A$ I I . A$ !
M 9! ! $%%/ H D 7E !
$/4&$67&8A1-&88$! 7
7II ! ! I I I IM @@ &%-%1 !
M . ! ! ! $%%8! D ( - ! ;
- ! $%%8? <&7$2<$-18! 7
7II ! ( ! I P I) Q ! I) Q I I P
P&$!%8!

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 31


Community pharmacists’ performance................

() -. / 0 * , 1 * ) 1 2 0 * * 3*4567
' )
4 6 G 8&!<< G &%!/:
39 /%
3) $%
= ! G &8!:& G &%!%&
= ! ( G &&!/2 G :!:1
9 ( 3
= <$!2%
T A1!2%
3
) A$!2%
) <1!2%
9 ( 3
0 1!2%
" :/!12
@ ( &%%
= G 2!22 G 8!8/
= ( ( G $1!2< G $$!&2
= G /!%A G /!&:
= G &2!/1 G &A!A<
9 3
T 1&!A%
= $2!%%
9 3
T /A!/%
= &$!2%
U) . 4
6!
U= ! B

() 8. , 1) 1, 1 * 1 * , *# ) , *
* " * 2
, 1 * * 397
2
#/ $
: $A 4$:6 21 41&6
- $1 4A86 2A 4<<6
-J A: 48:6 8& 42&6
- $$ 4$/6 2/ 41$6
->
$ 4A6 1/ 4:16

2 )) $$ 4$1!26 2/ 41$!26

32 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Azza Faturrohmah et al.

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 33


Community pharmacists’ performance................

34 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Chin Ken Lee et al.

EXPLORING RELATIONSHIP BETWEEN PUBLIC DEMOGRAPHIC


CHARACTERISTICS AND THEIR PERCEPTION ON PHARMACIST
AS HEALTHCARE PROVIDER

! "
# $ " "
! % " !
" #
% " % !
#& ' " ( )
* " ' % #
" +, ' # " $
" ! ! " %
-
# ' " #
.,, # % $ " !
,#/00 " ,#1..# !
% 2 3,#,+.4#
" " ! ! 5
" 2 3,#,.64# "
. ,,, ! %
2 3 ,#,,74 $ 2 3 ,#,+84
2 3 ,#,7+4
! % ! ! 2 3 ,#,,74 "
7 ,,, 7 1,,# "
6, ! ! % "
2 9,#,64# % ! : ! %
#
! %

!
$ " !
#7 " $ " " # !
" #
$ " " !
" # ;5 ! % "
% !

% #

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 35


Exploring relationship between...............

<%= >
7# % " % !
#
+# %
% #

"# $ %&
' " ( ) * "
' % #
" ! ! " %
# " "
#

" +, ' #
" $ " ! ! " %
-
# ' "
#

& " " ? $ ! ? ? 2? ?? 7@#,


! A 4# & " " B ) $ B ?
# ! " 9,#,6#

# ! !
.,, #
! " ! !
! ! ! "
% " " $ #
0.C 2 371,4 07C 2 37/.4 ! #
60#@C +, .6 ! " 0+#@C
#
% $ " ! ,#/00 " ,#1..

B !
! ' 28 AD 7 3,#,+@4
% 28 AD 7 3,#,+.4 #

" " ! ! 5
28 AD 7 3,#,.64 " # ! "
: -% 28 AD 7 3,#,,74 "
#

36 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Chin Ken Lee et al.

" . ,,, !
5 ! 2 3 ,#,,04 %
2 3 ,#,,74 $ 2 3 ,#,+84
2 3 ,#,7+4
! % ! ! 2 3 ,#,,74 "
7 ,,, 7 1,,#

% " !
6, ! ! % " "
2 9,#,64

!
% ! : ! %
#

% % " ! % %
!" #

# %#"#
B " $ $ < %# & ( )
* ! #

#'# # #
: $ #&# )#*# #*# E : F# B ! #B# +,7, G A
( ? > E % !
+,7,#
B % )# ? ?#;# ;# +,7,
! ! D #
& 8 /@H1.#
A *# F# * # # # +,,7 & ! %
5 ! >& 7/ 6.8 6.0#

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 37


Anila Impian et al.

! "# $% ! !
&&% !
'
& ( ) *+ ) , - .
/011 $"0 !
! - 2
3 4
$$1 ! ! "5 $%
! ! 4 *#& &%.
!
6$ $% &1 1%
*"/ /%. !
7 0 $% -
' ! ! - 66 /% "2%
' ! / &% ! 8
*+9 .
+

! "

3
;
! ! - -
< ! !
' *) ! /011.
=
4
! "#% !
! *+ - /002.
&&% ! *

38 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


How do indonesian community...............

/00#. '

#$ ! % &
3 ! =
3 ! & ( ) *+
) , - . /011 3 !
$"0
! ! - 2
3 ! ! !
' ! - '
3
! !

$ % !! "

8 !

! '
3 !
! -
$"0 ! - $$1
! ! ! 2/% = !
! 3 1

3 1 = 3 >

*?@$$1.
*%.
A :
/& $
#6 #
:
//B$2 #$ /
60B&2 // &
C&2 6$
! :
$1 6
? B "5 $
?

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 39


Anila Impian et al.

: #& &
9 1# #
3! 6
3 /5

: &0 2
9 6$ 2
+ 6"
? 0"

7 - *
! -.: 1" /
D10 $/ $
10B/0 $1 6
/1B$0 /0 1
C$0
7 - '
* .: 65
D& 15
&B10 /0
11B1& 16
C1&

#6 #%% ! *//B$2 .
! ! #$ /% ! "5 $% !
! ! ! !
* . 8
*#& &%.
! 6 "% !
3 65% & '
! -
3 !
-
'

'
3 / !
3 / 3

40 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


How do indonesian community...............

*?@$$1.
*%.

:
= 60 5
( /6 /
> /2 #
6&
9 05
3 :
&1 1
+ $&
&6
9 5&
>
:
//
E "/ /
11 2
9 1&
F - ! * ! G
G
: G .
2& 1G$G1 &
G0
-
55 #G" #G6
"G0
&" 6G1" &G
(' /6 #G/ 6
5"G# "G& 5
+ G0 $
"1G1/ /G/1
2G6
"# 6G1$ 6G
, 1# #G0 "
&$ 6G16 $G
> /2 "G/ 6
66 /G16 $G
E $6 /G#
56 &G#G" $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 41


Anila Impian et al.

G0 $
(
: "$ 6
H $& 6
?
> *?@/10.
:
15 /
&
$/
(' 61 6
9 $6
0

:
( 11 2
( $ /5 #
( " 1# 1
9 $"
9 "$
< : * G .
2/ 1G# 2
3 $/G"5
$2 $G"0 #
('
* G .
' :
1" &G5$ &
> "2G$1
" #G2$ $
/ &G2# &
+ ! & $G26 #
9
8 * G .

! : 50 /G12 5
5" "G1$ 6
5/ 2G1# 1
+ 5/ "G1# 6
+ "1 "G$5 6

42 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


How do indonesian community...............

7 !
! ! 60 5% 3 4 &1 1%
*"/ /%.
! "/ /%
- '
! ! ! - !
3 "0% ;
7 ! - -
= - !
- !
= ' 0 $%
-
"$ 6% !
! ' *61 6%.
! - -
!
;
3 4 *$"%.
3

! -
! ! - 3

!
' *"2%. ! " #% !
/ &% ! !
+ !
! - * .
3 !
! *A
> /002. 3 I
! "0%

" "%
+
! '
! +9
3

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 43


Anila Impian et al.

" '%$! $#$


• - A 8 ( > 7
, -
• - = *= .

• -

$($ $ "$
/00#
!
" # $ % $
& 3 + : 4 *A
+ .
A > /002 ' ( )*

8 /010 ' + " , ' -


$ ( 3 > :
(
+ /006 J= A :(
J. / *0: /$6B/61
+ - 8 /002 J 9
- > - *3
! .J $
& ) - : - - *
.
+I + ( + F I I - 8 - /00# J
: J
1 2 . $ / *0 ( 3 : /0$B/02

44 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ekarina R. Himawati et al.

!
" ! "
# " " "
!
$%
& " !
" !
" !
''( ) * $%
! + ,- $.
! "
/ 0% %. ! " 1 / 2% %. " / 23 3.
" 4 / 5 6. " " /
0 0. " " ! '
,, ,. ! " /
22 2. ! " 1 / 32 %. " 4 / 6 7. "
" / , ,. " " !

! 8 ! "

!"# $%&'#!$"
1 9 "
"
) " !
!
" " " :

; <
! "
" # # !
!
! "

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 45


History taking profile on.............

9 " 9
&! 4 "
! " #
4 ! " 4 ! "
= 4 "
>4 1
" / 4
! " /
4 / 4
4
=# &)= (+ ''( ) &? +'*
&?@ =*A+@= B ! # 3%%$
B "
# " = C )
) " D B
" ? ) ( 3%%% "
= C 3-, 2 %%% " 2,
! 3%%5
"
! ?
) A 3%%- B
"
! & " "
"
4 !
" "

+ " ! # "
!

( # $%$ $)*

+
": 6,%
& " = C " E ) 3%22 *
" #
!

& "
? " "
"

46 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ekarina R. Himawati et al.

,+
" " !
''( ) " 2

-
& 6 ! " E)
3%22 !
"
! " !
''( )

+
!

+ . +
?
! >
• 0
• " " "
"
• + F " "
1 "

• 1 # " !
"

+ .
?
! >
• 7%
• " " "
"
• + F " "
1 "

• 1 # " !
"

' +
A ! "
A ! " "
#2 " 2 ( !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 47


History taking profile on.............

Components The information being gathered/asked

W Who is the patient?

W What are the symptoms?

H How long have the symptoms been present?

A Action already taken; what medicines have been tried?

M Medication being taken for other problems?

% ' + (
& >
2 @ # "
3 @ " !
, ! # "
! " ! "
0 A ! " G

& # "% %! '& !$"


" = A
@ ? @ A & "
27,G *=AG8 )G3%22 B ! ) 9 3%22
"

$7 "
" " H
I 2 ! I 2
I2
I0

" !
?
!

48 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ekarina R. Himawati et al.

" 3 2" " ! "


! "

" 3 ( ! " ! "

Diarrhea Diarrhea in
History taking in Child Elderly
components being asked:
N (%) N (%)

Who is the patient 35 38,9 30 33,3


How old is the patient 36 40,0 10 11,1
Symptoms
Frequency of stools 11 12,2 21 23,3
Abdominal pain 2 2,2 0 0,0
Abdominal bloating/ 0 0,0
1 1,1
nausea/vomiting
Stool consistency 9 10,0 8 8,9
Other symptoms (fever) 1 1,1 0 0,0
How long have the symptoms 5 5,6
6 6,7
been present
Action already taken 6 6,7 3 3,3
Other medication being taken 0 0,0 3 3,3

2 ( ! " ! "

/
+ $% ,5 ,- $.
" 4
,% ,, ,. ! 4
? "

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 49


History taking profile on.............

"
? ! "

" 1
* 9 " "
" "
" "
D 2$$-

# 0% %. ! "
2% 22 2. ! 4
?
" ?
2 ! "
? " " H
"

! @ " #
# #
=#
" * 3%2%
=# " F

" "
" 9 "
"
4 "
! * "
! " /"
! "
4 " ! " "
+
H " ! " !
"
"
4
" 3 2 $% !
"
4 ! " 22 23 3. $

50 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ekarina R. Himawati et al.

- $. '
! " 22 23 3. 32 33 ,.
4 B
9
* 3%2% 8 5. ! " "
"
* ! " "
! 4 *
3%2%

, - 0
5 5 6. ! "
6 6 7. ! "
) " 9 "
" "
2 1 3 , ,
) 3%%3

+
" "
!
6 6 7. ! " " !
, , ,. ! 4
? " " !
" , , ,.
"

$ + 0 ,
" 3 2 ! "
" ! , , ,.
! " "
! " + A " "
) 9 8 # " "
" * 3%2%

'$"' & !$"

! 8 ! "

"'
B ! # 3%%$
) >B ! "

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 51


History taking profile on.............

D = C 2$$- @ & ' C @ @ ) =


3 A 8 = " 8 *
J ! & &
) 3%%$ ) K
C K 36- 3$ C 3%%$ $209$27
) BA A C A = 3%%- A ? " B
& A ) ' BL & 8 ) ) D
C) @ CA C *
J !> ) L 9( A ? ,%79,32
* 3%2% 3 8 >
2%%922%
! C : @ 3%%% !
>GG ! : G" 9 # 3 " 3%2%
' ( + H 3%%6 " #
! L > '(+
' ( + H 3%%6" $
$ L > '(+ 25932

52 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ida Ayu Alit Widhiartini et al.

! " # $
! !
%& #
! # ' % (
! ! ! # !
) * %( # *
% *
! ! ! )
# % ( ) "
! +,-% &
# +,- . % (
/ 012 3 #
# # +,- 445 # !
!6 % ( * ! ! #
%( ! #
! " !
/ 3 /
3 /# #3 %
( # %( # # 4
%7 2 /05% 83
) * 9
/0 %083 / 5% 83 9#
: # : / %583 /283
9 / %283 %
; 9 ( # * '
! ! * !
%( ! !
! ! %
9 * ! / * 3

!"#$ !
< ! ! 7 % &
< =) / <= 3

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 53


Identification of drug related...............

>>>1 444 >1 8% ( # 05120


/ 3
! >551 >> %
( 7 # !
44:% 7 # 7 # 48%
7 $ %
#
! %
! " # $
! !
% & #
! # '
%( ! ! ! #
! ) * %
/ 3
< !
' " %(
#
%(
# !
# % ( #
* % *
! ! ! )
# %

!%& ' ( ) "


! +,- ! 9
- 7 %
- 7 !
%

( )
! * #
! #
! ! %
$
% ( $
!
! # #
%<
! %

* +!",
& # +,-
. % ( #
#
! %( : %

54 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ida Ayu Alit Widhiartini et al.

( # ' # #
/ # # # # 3 $ !
445 # ) ! %(
* ! / 3
# ' % ( #
! ! %( ! # ! "
! /
3 / 3 /#
#3 % (
# %

*,#- , " " ,$#,, !


( # 4 # # #
/ ( ! 3% #
! # # # %( 010
# ! 01
0012 %( ? @#
# # 0 $ #
! % 7 #
# # ! !
! $ ! %( ! $
/ 3
! # # ! %( # ! $ %
( ! % & !
& / 3 ! /83

01
01 4 4
01
010
0 0012 :
( !

. " /0 ' %
' ;;.
" /0583 ! # ! &;=7 /
3 / : 283 &*. ) ! &*. /583
/ ( ! 3% & A ; @77 # !
!
! %& !
/ 3
! ! $ &;=7 %
( ! # ! ! $ #
! A ; @77
! # % #
/ 3
!
% # ! ! $ / 3

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 55


Identification of drug related...............

% ( # # # !
! # B % C 6
#
#
02
# %( $
! !
%
# ! /
! 3 &7 ! !
%( ! $
# # # %
( ! % * # & ! <
; +,- 445
D & D !
< /83
&;= 7 ! ; 0
* %2
&*. E 5 :%
;;. & 2 05
. . $ . 4%>
4%>
0 4%>
4%>
2 ) 7! F<;( %2
! ; F<;( %5
F 4%>
FG
: ! 1 : 2%
&

" / 0 % 1
( # 2 4 / 05 8
3 $ * # # $
/:3
$
% *
! # * % )
0> * / 83 # / 83 * *
! %
7 # ! * $ ' #
# ) * %. ' #
* ( ! %( / ! 0 3#
) * / ! 25 : 2 3# ) #
* # # ) * % ( ! * #
$ ' ! ! % ( !

56 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ida Ayu Alit Widhiartini et al.

! !
) * %
( ! %7 * <
; ( ! D / !
3
0 & <
& / F F F 3

* 0:5 0 & &


7 : & F &
& < &. H
; I I
G& / F F F F
F F F5F F F F 3
C 2> : 0 2 I(

<; ) !

=
( B / F F F F F F 3
E # 05 2 4 2 ! ( B G&
;
/ F F F F F F 3
< > & / F F 3
2 ; 1 ; 1
G& D ! I
; 1& / F:3
9 ) * ! )
* %2 # %

( % (
! I #
# $ $ %& A ; @77 !
! 4I54 < %(
! $
% # &;=7 &*. # 0
# &;=7 &*. # ! % ! !
! % # !
# % C ! ! ! $
% . ! $ ! !
/:3%
)

( # # !
%( # ! I . )
! & < & ! "
%

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 57


Identification of drug related...............

# # ! # ) # $
4 ! ) ! 0
< 0 # $
B 0 G 4 # # ! %
* ! ! ! B %
# !
/: >3
%( # # #
0 ) ! %

& # ! ! 24 G B 0 G 4
0 G 0 G 4 G G&
! %0I 044 ) ! G # #
/ 43
! # # 7G 7 %&
# ! # !
% $ "
%. !
"
%

# ! 4
# 7G 7 / 4 G 3% 7 $
)

)
/5 >3%

C # ) &;= !
# G& ! % !
G& % (
$ # ! B
/> 3
G& %

& *
# # !
# % & # 6 ' !
# ! #

# # ' %
! ' !
% $ !
'
' % ( * !
!
%

58 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Ida Ayu Alit Widhiartini et al.

$! $-#, !
7 * ! (
; +,- ;;. /0583 "
! # ! &;=7 / 3 / : 283 &*.
E ) ! &*. /583 %
C * # 2 4 /05% 83
9
/0 083 / 5% 83 9
# : #: / %583 />83
9 / %283 % ( !
%
$
! &;=7 ; & /D ! 3
& & & % ( !
! # !
! ' %

* * * $*
& 44>% < $ * $ $ ? $ %& ! 9
9II $$ $% I##I ) % J K L L K 2G 94: A
4 4
< ; E % >>4% G ! %& A
< % M :90 1 %
? @ &!! &$ 440% < @ 7 9 * !! ;
. : 9= %0 510 >%
D B ? 445% & 7 9 D B ?% ;
* ; = % %:421: >%
; *% A% >>5% ; ( D # <
;
A ; >> %
%C < @ 09 4 1 40%
D AM ; ! A% 44 % = ; <
* % A & & /23 ! 9 ###%
% I # I >> : A 44 %
B 44 % ( B 9 ! ! & %=
< A G G 1G 0%
$ 7 < 44 % 7 0 D . ; !
& 442% ; $ $ < A $ 9 $ .
?G ?E $ 6 . ? & ?
? %
* % @ $ ?? . ) < 44>% ; ! % # 9
###% $ % % >% %
%A % 440% % 9(
D #N< ;

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 59


J L Quah et al.

! " #
$ %" #$& ' % ( & )**+
' ' ' ! ,
" #$ ' '
! - ' - .
"
#$ - - ! # - - ' '
! ( ,/0 " #$ ' 1)
' 2 )**3 )**4 )**5 )**6 )*1*! # - '
%7 $& ' 5 )**+!
)**+ )**3 )**4 )**5 )**6 )*1* ' 54 1)5 15+
)88 )4* )58 - ! 3 '
- ' 9 :
%)**+;+4!*< )**3;38!*< )**4;3)!)< )**5;3+!8< )**6;4*!+< )*1*;36!*<&!
' = ,/0 - %
,/0>1!+ ,/0?8!+&! ' - =
- %)**+;14!4 )**3;15!6 )**4;13!4 )**5;13!8 )**6;1+!4
)*1*;14!1&! , .
" #$ - !/ - " #$
- - - !
@ '

!"# $%& #!$"


" ' - 16A* '
! , ' - ! ' -
1
' - 16+* ! B-
'
' = !) '
C %,/0&! D . '
- -
- - ,/0 )!*=A!*! D ' .
' -

60 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Five year evaluation of..............

- - =-
A
,/0 )!+=A!+!
-
!8 , ,/0 - '
- ! ' ' '
'
= = -
!) 8 + 3 4 - .
' ' : : 1 %E (0$1&
' = - - !5 -
' . =. ' -
! F : C C '
C ' !) 3 6
'
1*
!, ' -
= %#$& G
,/0 -
= - !) 8 6 1*
= - ' -
' ,/0 '
!) 6 = '
)4
!
" # $ %" #$& '
% ( & )**+ '
' ' ! , " #$ '
' !, ' C " #$
- - - ' -
%7 $& - ,/0 !
- ' - .
" #$ - - !

'# $%$ $

(
' ' ' ' ' '=
( % ( &" $ % ( &
!H )**+ (
' !D %#$&
' I 9 %7 $&! , )**+ -
' ' '
" #$! ,/0 ' - -
= -
C %#$J 4***2 , J , &! D 7 $ " #$
,/0 '
!

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 61


J L Quah et al.

% ( ) * +% ** , -
- ' - - ' '
! - ' - '
" #$ - 2 )**3 )**4 )**5 )**6 )*1*!
' - ' 7 $
5= %D 1 )**+ A* )**+&!
' - = - !
' ,/0 ' !
" ' ' .
,/0 '
!

.* * ,
' ' 15 !
- ' ,/0 - - ! ,/0 - '
' !
- ,/0 ' : ' !
- C ' % 8' &!

! /
" #$ '
!
! '
' = -
- '
= = = = !
G
- ' C
- ! , ' ' - !
'= -
11 1)
9 - ,/0! '

1*< ' ' . ! '


' - - - !

$ ,
' ' K *!)
,/0 % : &! K *!)
' ' . !8 3
$ ' ' ! % &
' ,/0 - '
= ! ' 0
1A
! '
,/0 ,/0 !1A

62 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Five year evaluation of..............

,/0 -
%,/0 > 1!+ ,/0 ? 8!+& ' ' - !

, * *
' L) ! 9
= ' !# ' ' = =
- M *!*+ ' ! '
% &E 14 N % ,/$! $ ,J 7 #&
E %E 9 $ /O 7 #& ' !

' & # "% %! & !$"


1 C !
)**+ )**3 )**4 )**5 )**6 )*1* ' 54
1)5 15+ )88 )4* )58 - ! 3 '
- ' 9 :
%)**+ ; +4!*< )**3 ; 38!*< )**4 ; 3)!)< )**5 ; 3+!8< )**6 ; 4*!+< )*1* ;
36!*<&! ' = ,/0 - %
,/0>1!+ ,/0?8!+&! ' - =
- %)**+;14!4 )**3;15!6 )**4;13!4 )**5;13!8 )**6;1+!4
)*1*;14!1&! 0 ) !

! = -
- - ' 8!8< )5< '
7 $ '
- !) 8 3 18 1+
' -
)
' 9 : !J
= %7 $&
!
,/0 : !)
, - " #$ ' '
,/0 ! = = - ' !
18 13
- - -
' ' ' -
,/0 - !
,/0 . ,/0 '
15!6 %)**3& 1+!4 %)**6& 14!1 )*1*! - ' -
-
!) ' -
- . '
' ' ' ! - '
'
! )*1* # (=
" % ' & ( ! '
' ' 9 ,/0!

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 63


J L Quah et al.

- '
: P' ' - ! (- -
' '
)
! ,
' " #$ '= !
-
' - -
!4 -
-
,/0 ! " #$ : -
- - !
- = '
- !4
# - " #$
8 1* 1+ 14
- - ' ,/0
= ' - ' ,/0=
C !
' - ' -
- ! D ' :
' 9 !
D '= ' - ! ,
' '= .
!
- !
- - -
- - ! / -
' :
!6
' ' %
- & ' ' ' '
!3
( ' - '
' :
!# - - -
: !
'
" #$ - ! - '
!

$" & !$"


, . " #$
- !/ - " #$
- - - !

64 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Five year evaluation of..............

"$ '% ' '"#


(
( ' !" '
!

'-' '" '


D H ! @
Q @ R ! )**+26*%A&!
' $J H / J !F
= C
' ! ! )**52)5@)*=3!
H # 0 H ! H /
D +1! 7 @ 0 ! )**3 !
$ D" " 0 J " $ O $ O R ! $
' ' - S -
C !H R $ ! )**32 3)%+&@3*1=6!
" 0 B H ' D R! , - ( C
, - - @ # $ B B-
" ! , - - R @ , -
R ! 11%1&!
" R " - R J ' R H B !$ .
@
C !$ # R ! )**A2136%8&@)6A=5!
#! B # - ,/0 E 0
$ T U! 7 - 2 )**+!
E J O R 0 R D D " H ! #
- : 1 %E (0$1& - ' '
$ ! ! )**+21+@354=61!
" ' # / B# H R R R R !(
- = -
!$ R ! )**321A*@1A5+=6!
$ # /# 0 C !$
' ! R#HD ! )**1218%1&!
! = " $
( ! )**+!
@' ! J @ !
)**4!
0 D0 $ $ - DR H B! #
! 166A2A6@)A3=6!
" # 0J CC R! B C
- ! $ B )**+2
1)4%+&@ 1+1+=))!
$ . B # H ,! $ '
!# , 166521+5@1381=4!
# R J # !# !$ )**12
116% &@ 168 =)*3 !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 65


J L Quah et al.

" E R # (, ! ( =
- ! ! 166+21+@1381=4!

Table 1: Demographic characteristics of warfarin patients in HDOK from 2005 to 2010


Characteristics 2005 2006 2007 2008 2009 2010
(Control) (WMTAC) (WMTAC) (WMTAC) (WMTAC) (WMTAC)
Age Mean ± SD 55.1 56.1 57.9 58.0 58.1 58.9
(years) ±15.8 ±14.3 ±14.7 ±15.2 ±15.9 ±15.8
Range 20 - 85 18 - 86 19 - 87 18 - 91 18 - 90 18 - 87
(years)
Sex Male 71 111 146 157 163
43 (49.4%)
(55.5%) (60%) (59.8%) (58.1%) (57.4%)
Female 57 74 98 113 121
44 (50.6%)
(44.5%) (40%) (40.2%) (41.9%) (42.5%)
Race Chinese 35 51 73 98 110 114
(40.2%) (39.8%) (39.5%) (40.2%) (40.7%) (40.1%)
Sabah 48 65 93 121 140 145
Bumi (55.2%) (50.8%) (50.3%) (49.6%) (51.9%) (51.1%)
Others 4 12 19 25 20 22
(4.6%) (9.4%) (10.3%) (10.2%) (7.4%) (7.7%)
INR 2.0-3.0 43 (49.4%) 72 112 164 189 210
Target (56.3%) (60.5%) (67.2%) (70.0%) (73.9%)
2.5-3.5 20 18 26 31 34 35
(23.0%) (14.1%) (14.1%) (12.7%) (12.6%) (12.3%)
1.5-2.5 18 27 33 32 28 25
(20.7%) (21.1%) (17.8%) (13.1%) (10.4%) (8.8%)
Others 6 11 14 17 19 14
(6.9%) (8.6%) (7.6%) (7.0%) (7.0%) (4.9%)
Indication Atrial 55 98 134 177 191 197
fibrillation (63.2%) (76.6%) (72.4%) (72.5%) (70.7%) (69.4%)
Heart valve 25 21 33 41 48 48
replaceme (28.7%) (16.4%) (17.8%) (16.8%) (17.8%) (16.9%)
nt
DVT/PE 4 5 9 13 15 20
(4.6%) (3.9%) (4.9%) (5.3%) (5.6%) (7.0%)
ICMP 0 2 5 4 8 10
(0%) (1.6%) (2.7%) (1.6%) (3.0%) (3.5%)
Others 3 (3.4%) 2 (1.6%) 4 (2.2%) 9 (3.7%) 8 (3.0%) 9 (3.2%)

66 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Five year evaluation of..............

Table 2: Anticoagulation Control of warfarin patients in HDOK from 2005 to 2010.

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 67


M. Caecilia N Setiawati H et al.

! "
#$ " % & # # ' % ( # )
" %' # ' * % &# ( + #
& # " # & # ( ) " ' ' % *
% + & % # *% % " ' '' ( , %
* # %) # ' % " + " ## + #
# % - "" " % ) "" " % )% # % && # ' &
" ( % + " & % " # ' ' + %# & ./
" + " ## + " 0 % " %1
//2 3 1 / / + % + # ' % " " % #
45/6 ) "" " % 4576 ) ' % 4 86 ) * " # % 476 ) %
" % # 4 86 ( 9. " 42/ 6 # % * ) " 4 6
& # % ) " 4 6 + %+ " ) "
476 + % %
!"# ! " # $ )% ' ) && # ' " ) "

$ %&'() %$'
$ " & # #" + & +% ' &# #
' % ($ % & % # % && " #" # # # 0 %*
&* % # ' & ' # # # * % (
" & ' # ## ' +
# " ) %' # ' * % &# (
+ # & # " # &# ( ) " ' '
%* % + & % # *% % " ' '' (
$ ) & : # % * " # # )+ %
# &% % ///) ## & .)/// % (
# ) % ) " " ' ' % (, & " & "
% ) ' % % % & & # % % % ( & ;
%& ' % " ; " ) # * % & + - " # ' )
" ## ) ' # # % * # ( <& % " ##
# % 4! % ) ///- 2
" #&# %# # * ' & " # * && % #
# " %" ' " ## )* %# ' ) && # ' &
" # # * # # ( =& # "" ) %# " # *
* % & # " # * ' %( $ %# % " '

68 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Drug use evaluation of..............

% )# # # " # %" ' ' # # 4 )


//5- 9/ (
>' %# %# ' && # ' ) & '
%# % ) # * # + (
, % * # %) # ' % " +
" ## + # # % - "" " % ) "" " % )% # %
&& # ' & " (

% '('*'+,
% & + % % # " ' )+ % # # + # % # %
" # ' ( * # & # + " %* " &
" ; & % " % &1 //2 ? 1 / /
% & & % # ' # ( # ' # # ' % " + +
% % " ## + + % % (, % # ./
* # + & %(

& )*% - ( ($ ) $'


". / "
+ & * # + & + % % % %( % + 2
% & ( =# % ) " + 9 3./ % . 37/
4 # 76 ( , # %# # # & # ; * # + + * (
# " % % " ; " % + % # % %
+ && ' # + ) - 4 ) //5- .

( )" 0
=& % + %) + & % ." 4 /6 + ' "" "
% % ." 45/6 + "" (
% %% * ' ( " )+ & % *
# # + % 4 @ ). ? 8 A% ) * % % # '
" 4% * % & ( 5 %# ) 5 % )
* %% # ' " # ( " + & % *
# # + +) * %% ; # ' " (
' + %# ( 7) # ' ' % B +
% & " "% # ( C " 0 %$ " & " /( D + * &
" /( = " 0 & " % E & " 2 = " %
D& " % .+ ' + # %# % (B *
# * "" %* # " % " % &+ %# # %(
F' % ( + ' $ & E & % ( + )
## % 4 " ) //8 - 9 # % % $ & E & . ? / % (
" # " " .) " + ' % E % " " '
# ' % ) # & ) * # ' % ) & %* &(
G % ( 8 " 457 6 % "" " % ) " 476
* " #% ) # " % & " 9) # & " 8
% H #& " 9/( # %# && # ' ) %+ % &
( # ' ' % % + 24 86 # # I 0 " 0 "

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 69


M. Caecilia N Setiawati H et al.

.) 9) 7) 5 % " 9/( H E + ' " 9( <' % H$


" # % " % ' % % " 9/)
% % & " 98( F ' ' % % # % # E# %
% && # ) * # % * & %# " ; %# # %(

(
% ) & +" # # + & %* + % '
" ( # " % + + * (
% 3% # + * + = #% % " 4 # @ 76 (
= #% # % % # * * & " + + ' (
# "" % " ( 7) % 7(
, % )$ " " + # # + " % %
# # " 4 # J ) //8 - / ( # "" % " 5
+ " ; * %" 2 //2 @ 9/A / ! % # + % +
2/A2/ ! /= //2(
=## % 4 # J ) //7 - 8 2 + & % # * +
$" & E # % %( $ " & E # # % " && # &
%) # "" % " 9( < . < * //2) " ;
* %" % # & /A8/ ! /A8/ ! (
% " # % # ## %
4 # J ) //8 - 85 F % % & ' # # # % # %
& E# % & E #) * && # # % * * ' %% # (

11 0 "" / 2
=## % " ; %# # % )+ + # % & " +
' ! " ( ./ " ) 9. " " 42/ 6 # % * ) " 4 6
& # % ) " 4 6 + %+ " ) "
+ % %( =## % 4 # ) //. - 925 % " &
# # % & %) * # + ; %# # % #
" &* " # ( &# " %#
& % ' % 4 ( () " $ ,) # ) 3 # #
" ) % " ' A % & # " # &# (

' *) $'
& >' & I' # "
) + % + # ' % " " %
# 45/6 ) "" " % 4576 ) ' % 4 86 ) * " #% 476 )
%" % # 4 86 ( 9. " 42/ 6 # % * ) "
4 6 & # % ) " 4 6 + %+ " %
" + % %(

70 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Drug use evaluation of..............

- '3* (+ %
% 4 - !" 4 ! 5 1 / 2 / "" $ / $ 2 ".
$ " 1 & )( % 6 ! 7 889 : 7 8 8

= 4 # 46
B

K@ / 9
3 9/ 5 8 7
9 3 ./ 7
. 3 7/ / 7
7 3 5/ 8
5 ? 8/ 7

2 ./ //

% 4 ( ." 1 / 2 / "" $ / $ 2 ". $ " 1


& )( % 6 ! 7 889 : 7 8 8
( $ 4 % " ;<

- "! : 2 7) ) 7 7
2 2 :- 2 5
2 2 : 2 5
2 2 :! 5 2
2 2 := " ! 5
2 1 5 := " ! 9
= " !:* 2

= " !:- 2/

= " !:+

% <

& 1 "
" ) 1( () , ) B(=() G ) ,(F() # + ) (I() B ) (B() H ) B(D()
# " ) 1($( //8( ( B#F +( =-!
$ " #
>' ) B($( //.( =! ( = - = # # & !
#

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 71


M. Caecilia N Setiawati H et al.

) >( =( //.( (= * -
(= * - ' (
! "-AA+++( % ## # (# A " 6 / %6 / * # A=6 /, &6 /! 6 /
& /B % # 6 /> ("%&) 4 9 " * / / ! % ) ( ///( ! " (
% (, % -B % B F L ) B( () = % M $N % ) B( () O #
= ) B( () % 1 %M ) B( () //9)B &$ %= # )D > 1
B % P ./- 7973.9(
F # F3 )B )1 " I )B %B * & O =Q ! " $
# $ ) //2) B % & G $
% ! " - !" P /9- 8/ ? 8 2P
# ) (=() G ) I(B( //.( # # $ ( %* % )
,( () ! ) !()G ) () B ) (=( >% O ( O (1 - >F$
# ( //8( (> >% (I % - # #
) !(=() = * ) !(D() I ) I(=() D ) !(B( ( //5( $ % $ (
>% (1 -1 * %

72 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Mufarrihah et al.

! "
# # $%&%
' ($ )
*
' + ,
-$ ./ 0
1% 1/ 2% ./ 11 $/
.& $/
"
#

34 5

$$%
& 16/ 4789 $%%25 9

4789 $%&&5

4
5 4 5
4 5

:
;

<
"
4 $%%25

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 73


Profile of housewifes’ knowledge...................

" # $%
# # $%&%

# ' ($
*
' +

" # !
($ 2= (/ (%>(6 &6 $/
1%>16 $2 &/ =%>.% &2 (/ 1% 0
4=. 2/5 ( -/

& ' '


) ? ,
2%>26 &2 (/
1%>16 &6 $/
(%>(6 2= (/
=%>.% $2 &/
@ .% 2 6/
: 2 6/
A A & 6/
B C &. 2/
# =. 2/
( -/
: . ./

, -$ ./
0 1% 1/ 2% -/
11 $/ .& $/
(% %/

$, "D
, ? 7 ' "
-$ ./ &( 1/ & 6/
0 1% 1/ (2 -/ ( -/
? 2% -/ =( 1/ 2 -/
11 $/ (& 6/ 2 6/
.& $/ $2 &/ ( ./

(% %/ 1- &/ & 6/

74 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Mufarrihah et al.

B (%/ !

; 8
0 +
4? $%%=E D $%%-E $%&%5
"

+
;

4789 $%%25 ? &6.%


&66%
8 &66%
&66.>$%%&
+

#
" 4< $%%6E ?
$%&%E F ; $%&%5 +

! !#
8 " #

! #" $" "


:

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 75


Profile of housewifes’ knowledge...................

"&" " !"


F F D ' 0 ; $%%2 A A

< 0 B # # B; # # 0 ? C7 $%%6
8 ? * , ? A 8
A 3< 8 ?
8 A ? &$2 $62>2%%
? 7 C # 0
F , ! ? < A
# < $%&% ?
8)
G, $1 1(>(.
? C < # A; ! F C
$%%= 3 2=- 46(165 &-&%>&-$.
F ; D < ' $%&% , < # '
8 ! 2&
266>1&-
8 ? ? < 0 < 8 ' ' # C
C 0 ' A $%%- ? A
3 ? " # $ %
&&&4=5 &2(6>&2=6
D D # # ) < C < $%%-
A $%%$ : # F
& ..4&5 &%>$&
0 , 0 ' < A $%&% <
' % 2$4&&5 &($>&.1
789 $%%2 3 9 7 8 9 ;
789 $%&& # : 2(& 7 8 9 ;

76 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Nanang Munif Yasin et al.

"!#$%!&' ( %)# * +
* , * - "!#.*
( "!#$%!&' * -/ + ( *
"!#$%!&' * * *
* * -/
+ ( * "!#$%!&' * - 0 .
,* + * ,* ** +
- 12 "!#$%!&' * + * * * - & +
3 ( 4"5 ( 6 78)9 * :
3 - /
3 * ( + + ;21-<=> +
* + 3 + ; <=>- /
( + ;?2 > *
;?1 <?> * ;?1 @ > + * ;? 2>- / +
3 + ( "!#$%!&' * -
"!#$%!&' ( 4"5A 6.8)9 *

"!#$%!&' 3 * 3 * 3 ! -
A 6 ;A 6> * * + .3
* ** + + -
A 6 3 ( *
3 + 3 + .3
** -A 6 3 .
3 + * + .3
** + : + ; -
BB<>-
" . ( ;")A56> 3
* * * * - "!#$%!&'
3 * :
")A56-
% ")A56 3 C * +
"!#$%!&' 5 ' "!# " ' ; 5'."!#> A
4 .8 "!#.A61 "%/.A 6 %!&'."%A "5 9' A 6."!# %"!
9 .A 6 4"5A56."!# ;' - BB@>-
4 " 5 C ;4"5> * . (
4"5A56. BB ! ;% BB?>-

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 77


Quality of life in...................

/ 4"5A56 3 ( + *
* - 4"5A56.8)9 2. 33
4"5A56 ;% BB?>-
/ 3 + + ( * "!#$%!&' *
* * *
* D +( *
"!#$%!&' * -

! " #
/ + . ,* "!# $ %!&'
* * * -
& + 4"5A 6.8)9 (
3 "!#$%!&' * B 0 3 BB< B 3 B B-
) * + * + "!# $ %!&' + *
3 * * * ( 3 + E
* %)# * +
( ** ; >-
+ , * + + "!# $ %!&'
1 * + * 3
* -
/ + C 3 * -

"

$ % % &' &% %&


/ 3 + ( + B. <
*; ? -@=>- "!# * B.1B "!#
- /
* + ; 1 21-<=> 3 *
3 , 3 - /
* * ; 2<-?=> +
* ; 2 @ - =>-
( )* & + , -' & % % ' - % . /012
# 3 F 0 =
1 21-<
1 12-
% B. < - ? -@
1B.1< - ? 1 -<
?B.?< - 1-<
B. < - -2
6 9 1 -1
G " ' 1 -1
" ' 2<-?
% 1-<
5 * 9 * 2 @ -

78 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Nanang Munif Yasin et al.

* B @-

) " , ? 1 -<
" , H -
" , 1 -1
! & ? 1 -<
! & H ? -
" ,
F ' ! 1-<
' ' !! 1B-2
' !!! < -
' !# -
%)# I B
& .1 2 ??-?
J1 -
+ -

/ "!# ? ;1 -<=> * + *
, ? ;1 -<=> * + -5
* <; - => + !!! ; B=>
%)# * -

3 %% "
* * ( ;21-<=> B
* * ; @- => + * ( 3 - * 3 *
; -<=> ? * * ; - => + *
+ -
4"5A 6.8)9 ( (
* * * -
4"5A 6.8)9 (
3 * ;'
BB >- ! 3
-% ( 3 / 3 -

( 4* 3 " ,
3 " , 5
?1 <?K ?@
?1 @ K< B@
' ? 2K 1<
9 ?2 K2 ?

' 0 ; BB >
- ( +
** 3 -

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 79


Quality of life in...................

' + + -/
* 3 3 3 * + * *
+ "!#- % 0 ; BB > * + "!# $ %!&' 3
-

$ % % &' &% &% & % 3 "


! * +
+ 3 * + + *
** * -
! 0 ; BB > 0 ; BB > + +
( 3 + 3 *
"!# $ %!&' -

( 0* # 3 " &
3 " , 6 ,
?1 @B ?? 1
?1 < ?1 ?2
' ? 2 ? 2<
9 ?2 @ ?2 2<

/ 3 ? + ( * + +
* + 3 -

( 7* && - % 3 " &


3 " , ,- ,-
?? 2 ?
? ?B
' ?1 B? ? ?
9 ?@ ?2 ?

/ 0 ; BB > 4 ; BB2> *
+ + ( + + -
"!# * L 3- ' * ( 3
3 - / 3 %!&' * 3
"!#$%!&' + + ** +
* + ;& 3 BBB>-

( 8* & % 3 " &


3 " , % % % %
9
?B ?? ? 2 1 BB
B ? B< ?1 BB B BB
' B ? 1< ?@ 1 BB
9 1 2B ?@ @ ?? < ?? BB

80 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Nanang Munif Yasin et al.

8 3 *
* -/
! 3 * * 3
+ "!#$ %!&'-
3 * 3 * + "!# $
%!&' 3 ;& 3 BBB>- / +
+ *
( -
! * %)# *
*+ %)#
3 * 3 -

( 1* 9 ' - % 3 " &


3 " , :) )+0 ;0
? @ ?2 1 B BB
?B 1 ?2 2 BB
' ?B 2 ?1 1 2< BB
9 ?2 2@ ?2 < 2 BB

"
/ ( + ;?2- >D
+ 3 * ( + ;21-<=>
* + 3 + ; -<=>- / +
3 + ( "!#$%!&' * -

<" #
/ +

6
% BB? M / 4 " 5 AC 6 ;4"5A56>.8)9
& - )C ' &- ' G + 4 "
5 C *E$$+++-* * - $ C $ .
+ ( $! $* ? 3 BB<-
& 3 N- BBB <.< <1 BB. B
. < @ . @< 3
! & -
%- %- M- F- 5 3 M- - BB< A * *
+ "!#$%!&' M ' 0 ! " #$ ! % 9 * ))
0 - E . @
0 8- & M-)- & #-'- # + M- BB A "!#$%!&'
* E% . ! ! " # & 9 , 4= .
@ *E$$+++- - $ , - * BB $ <$ $ $? @B B B-

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 81


Quality of life in...................

0 - % 3 M- ) 3 - BB " .) A 6 +
"!#$%!&' ' # % 9 , )) 0 2 BB E 2B 7 2 -
' - ' G- F- F- )- ' 3 )- 4- BB@
* 4"5A56.8)9 ./"%! + "!#$%!&'
& ??<.2B
' '- 5:F M ' , '- BB 4"5A56 * & *
4 " 5 C : A 6 "!# E %
# D 8>E <. @ *E$$ - $* $ - @ B B-
4 0- 6 )- "- % #- F- - % + '-M- BB2 / * "!#$%!&'
( E% ! ! " #
9 , 1? 1. *E$$+++- - $ , - * BB2$2B$ $1$ <2@B
B B-

82 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Shim Y.W et al.

! !
! " # $% &
! '() * +,
- $ ./ & 0 !
! 1 2 3 %
4 3%*5 ! *
$% ! !
* * 6 , $ % 78 !
9: '() ! $3 ! ;< 4.:$8=5 !
.>$<$ 3 '() * * 6, ; ? /$8>@$ 3
A % ! !
! ! '()B>$.$ 8@$;.= ! ! /$. '()
$ '() & C;$/ ;$/D>$. B>$. 8:$::= 89$;8=
;/= ! ! /$. '() & $3 ! 78
$E 9>$8/= * 6,
8>$>/= ! ;<$8/= ! $ 3
! ! $'
'() * * 6 ,
'() ! >$. * * 6 , &
$
! D D * * 6,

" #$% " #


2 ! &
$3 1 -'
( 0 ) 4'()5 & " !
! $
! !
! " # $ 3
& -' 0 4'()5$
% F $ 4;//85 " ! 7! $

E
& ' ( 0 ) 4'()5

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 83


Comparison of a portable.........

& $% & 2
& ! $3 ! -
& ! ;$8 & 4G ;/@/5$

2 3 % * 4 3%*5 &
& ! ! & &
$ % ! &
& & !
& & $* & !

$ 3 ! ! -
& !$


% * , &
'() $3 & &
! '() $ 3 !
! &
2 3%*$

% 2 3%* & 2

3%* ! * ,

$3 * , &
1 $


& * , 4 ;//8H (
$ ;//8H ) $ ;//8H 1D3 $ ;//8H A 0 $ ;//<H *
;//<H * ;//<H I $ ;//<H $ ;//<5$ ! &

& * , $

&"'#$# #(

$ ) ** )

3 ! & $ '() * ,
! '() &
$

+ + * * )
3 ! ! ./
! ! 2 3%* $3
! I 2 3%*
$

3 ! & ! !
F ;/@/ ;/@@$

84 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Shim Y.W et al.

,- +* .
J ! & " ;$.
>$8= $% ! H
'I3 ! ' ' @$@7 '() %*I
</// & 0 4' I %DJ
0 ' 5$ J '() 0 !
!
& $

/, . ) 0 1 +* .

* , 4) 5!
- '() - $ % " @/
 
! * %
& $3 ! &
! " & $

2 3*
! &
$ * & '() &

! * , !
& $


% '() * , !
! ! '() ! %*I <///$ 3
'() %*I </// ! !
& $3 !
E '() & !$

$ *

3 * , !
$ & !
'() /$. '() C;$/ ;$/D>$. B >$.$ % D

! '() * , $ )
 
* , ! '() * ,
$ % A D% !

! '() * , $

& % " $$ % #

$ ) + 3 +* . + )
3 0 ! ./ ! 78
$E ! !
! $E 78 1 4.:$>=5 !
$ ! A 4.:$>=5$ *

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 85


Comparison of a portable.........

7@$<= ! % $3
! .>$<9 $
3 ! !
47<$9/=5 & & 47>$8/=5$

% ! .;$>/= '() ;$/ >$/$ >.$7/=


;$. >$. 8$>/= @$. ;$. 7$;/=
;$/ ;$. ;$. >$/ & $ 3
! .9$<< 4 @8 >:/ 5$

#4 4 3 / . ) 0 * /
3 ! '() ! /$@9@88

4 ?/$//@5$ '() * * , 4 ? ;$</5 !
'() 4 ? ;$./5$


78 '() & ! * ,
$ 8@$;.= ! ! /$. '() $
'() & C;$/ ;$/D>$. 8:$::= 89$;8 ! !
/$. '() & $3 ;/$//= '() & >$.$

6
% * * , !
6
;/$8>= * * , /$. '()
$

6
3 '() & * * ,
! /$. '() $ ! & !
'() & >$.$ 3 !
6
$ ' * * , !
! '() @$. >$.$ A '() &
6
* * , '() &
4 ?/$//@5$

* 3 / * / . ) 0 1

A 4 5 * , '() &
! ! '() & 4 ?/$8>;; C/$///@
?/$/.5$

3 ! 4
4;//85 ( $4;//85 ) $4;//85 1D3 $ 4;//85 A 0
$4;//<5 * 4;//<5 * 4;//<5 $4;//<5 I $4;//<5$
! & A % 4@98:5
4 ;5 ! ! &
$3 ! " !
6
'() * * , $

86 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Shim Y.W et al.

. 3 / . ) 0 1 * /
3 A D% 4 5 & ! !
$ ! & ! & '() &
6
>$.$ 3 '() 4I * * , 5! D/$@9$

3 ! ( $ 4;//85 ) $ 4;//85 *
4;//<5 $ 4;//<5$ 3 !
$

2 + 3 )

9>$8/= 49.= *' 8<$.7D@//$/:5 * ,
& $ 1 48>$>>=5
6
* * , & '() ! $
6
;<$/8= * * ,
6
$ E * * ,
48$>>=5 & 47$@:=5 & 4;$/8=5
! ! 4;$/8=5$

6
1 * * , $3
6
! $3 * * ,
! ! $ ! & >

& !
6
* * , $

# % #
6
3 & '() * * ,
$ ! & '() & >$.$ A
'() ! @$. >$.
6
$ * * , &
$

# &$(& & "


3 ! 2
3%* $ 3 )

* $

&5& & &


A 0 I$)$ F $I$ $ $ F K$*$ $%$ F $ $ ;//<
% * L * , ' (
) % 2 D :/ >@@D>@7
A F$ $ % $ $ @98: % % A ! 3!
E * >/<D>@/
* F$M$ 0 $ *$ $ L %$ $ G F$I$ M M$ A$3$ ( ($ $
$ $ ;//< * * ' (

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 87


Comparison of a portable.........

) 4'()5 ) A ! * , * & I

* A$ $ $ $ % ) $ N N$ 2 % 2$%$ ;//< *
& I '() L &
* @.4;5 .9D:;
A$ $ A '' )$ $ * )$ A I$ $ $F$ ;//8 %
* 2 A ' ( 0 ) *
* , D 3%3 @ D D* % 0
@>/4@5 88D9;
$*$ I 3$ $ ( $F$ I I$ $ ;//8 K& * * , 3
8<4@@5 9/.D@/
F %$ F $ K $ % F$ *$ $ ;//8
J % !"# @>> @:/D@98
I F$ $ I $ $ $ $ I $ $ * $'$ * M$ $ ;//< K&
* * 6, 3 ) & I D
E % 3 $ % ;< @<<D@8@
( $ $ ) $ $ $($ I *$ $ M$ $ I $($ * M$ ;//8 K&
) * * , * % 0 * E *
& " >84@5 ><D7/
G F$I$ ;/@/ 2 3 & 2 3%* &

) $ E- $ A $ ;//8 3 ) D D* 3
6 6
3 $ % * * , '() !
I ' >; ;:D>>
1D3 $ $ A$ * $ %$ ;//9 %
* L * * , * & 2
2 E # ( @;>4:5 9/9D9@>

)* '+(

88 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Shim Y.W et al.

) " , '+( -. /"

1.0

+1.96 SD
INR (Laboratory) - INR (CoaguChek XS)

0.5 0.53

0.0
Mean
-0.19

-0.5

-1.96 SD
-1.0 -0.92

-1.5
1 2 3 4 5 6
AVERAGE of INR (Laboratory) and INR (CoaguChek XS)

) 0 '+(
-. /"

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 89


Soemiati et al.

!
" ! #
$ %
&
' ( ) & ) *
& ) * &
* +,-, ./ &
&
0)
1 2+ 34 )
/5 /4 ) .5 +4 )
.+ .4 ) 35 34 )
& ( )
& ) * ! ) $
6

7" ) #

!
" ! #
$
8 ., -,, "
+,-,# 9!: 6
! " +,,;# 6 ;,<
! ., ,,, " +,,;# & 6

6
6 = ! !
+,,/ &

90 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Profile of housewifes’...................

! : ) !

!
& & ) *
* 6 +,-, +-,, ! * 3/,
& ) & )
* )

" # $%
& & ) * * +,-,
./ &
&
0 )

9
6

" # !
: ./ << /4 ., ./ ++ ,4 5, 5/
++ ,4 ;, 2, 5, =
";+ 24# ; 34
& -
> ? 1
<, </ -- /4
5, 5/ ++ ,4
., ./ << /4
;, 2, ++ ,4
@ 2, . -4
8 . -4
A A - 24
B C -3 ;4
* ;+ 24
; 34
8 -, +4

1 2+ 34 )
/5 /4 ) .5 +4 ) .+ .4 )
35 24 )

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 91


Soemiati et al.

& + 1 (%
1 ? 9
? 2+ 34 +2 +4
& > /5 /4 . -4
& = /; ;4 < 54
* .5 +4 5. 34
.+ .4 52 .4
35 24 -. <4

&
D
) ) ! E &
) ) ! *

$ " $ +,,.# )

$ '

= $ !
( ) 6 +,,3 ' +,
7 "-#
"+# $ "<#
"5# " +,,2# &
)

&
! !
"F +,--#
* 6
! 6 "% +,,<G ! +,,;# 6
"% -//2# &

!
& (
! &
6

&
() ) (
"9 +,,+G +,,;G ? +,,2#
&
& ) )

92 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Profile of housewifes’...................

! !#
! ( ) & ) *
! ) $ 6

! #" $" "


8

"&" " !"


* ! % 8 1 % * ! ?
= ( * 9 D ! ) H % 1
? F D ) ) C D +,,;
)
C ) 6 +,,5
-,,"/# 3.. 3;+
? C ? 9 ? ! +,,2 * )

-3 ;, * .
B C ! A 9 D D ! 8* 1 ?
8 = ! 8 & ! & & C +,,; &
9!: 7
<;3 -2, -2<
F +,-, & 1 & 7 1
5"<# <<. <</
C ) F D 1 F $ = F * ? % * B
B = ? C B B ! ) : 1 8 = D %
9!:I& 1 * 9 ) F +,,2 A 7&
-+7 ;/.J
;//
F C +,-, A I
+- ! "
-,"+# #$%&#'$
! % +,,; * " ! # 9 D
* 6 ( )) ( ! <3"+# -+5 -+/
% 1 ) % % % * F 1* * +,,< 6
6 = I ! ? 6 6 7
+,,- ! * +2 -;< -;2
K $ F ? B * ! F L 1 A C ? ) F F +,,. %
1 "?

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 93


Soemiati et al.

1 M # )
* -2"5# +5< +.<
= ) 1= +,,; )
* !? D
) = & 1 F !
* % ) D
9 C B A C F 1 $ = 1 $ $ F F ? )
C F +,,+ )( ( ( ( ;2"5# <;<J<2,

94 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Umi Athijah et al.

!
"
! ! !
! #$ !
! !
!
!
! % #$ &
! '( () *''+(&, !

- " !
( () * .+(&, % ! "
/ ! ! 0 ) *.+(&, " 1 0) *1+(&,
) * +(&, ! - !
! ) * +(&, 2
"
3 .1 0) *&&+(&, & ') * '+(&,
'$ .) * .+(&, 1 0) *1+(&, 1 0) *1+(&,
1) * +(&, ) * +(&,
! .& #) *&.+(&,
" ! !

! "
4
5
-
6 7 *68 98
5 $$1, 7 !
!
! 3
3 * $ , 7 !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 95


The profile of prescription................

:! ! -
: ;
< ! -= : 3

!
! -
* 5 - $$#,
>
6 2 7 ? $ 0 $$1
!
3

-
*68 98 5 $$1,

! !
*68 98 5 $$1, %

*
$$#,
6 2 *62, !
! 62 @
! !
* 6
$$#,
62 !
-
!

6 5 *65 ,
62 ! ! !

A ! 62
! !

# $ ! %
B ! @
!
*; $$.,
? ! .'$
! /

- 6
-

96 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Umi Athijah et al.

- !
-
!
! ! '$
! * , ! !
!
8 *C
9 2 - ,
8 D B *- - D !
,

&' () * + '
* + '

!
'
1 *
,
&
. - 3 ! -
3
0 - 3 ! -
! E E E E
( -
* ,
# - - !
* - , ! -

&' (* )+
&
) +
# 2 4
8F 3
3
+ ?
- + G
62
$ 7 ' - * ,
> 0$ + C* . + C,
% 4
! 6 4
+

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 97


The profile of prescription................

) % ) ! ! )" )) )
#$ ! (& *#1 1),

( )+ , - .
! '' *'( (),
-
*% B, 3
! *68 98 5
$$., ! ! ! !
3 * , '
!

&' /( ! 0 * &'

* &'
H5 ''

H !
3
!
* , #
H ?

H ;
* + ,

1( )+ ,* + + ') &'
5 ! !

"( )+ , "' + '"


!
F
E 4 8F
- 3 F /: ! :
:; : :7 ! : :
: :; : :6 :
*- ! 28 7%6,
*> - F $$ ,
1 ! 3 ! -
3 ! - ! 3 !
3 F ! & !
! !

98 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences


Umi Athijah et al.

&' 2( & 34 &

& 3
34
* +
& 5
*
$ .&
'
1
' '
' & 3
67
0 +
- 3. 8(2

% &

!
-
!
F 3 :6
- : 6

&' 7( ! & 3* + ) 33 *
" 0 3 9:;
H ! I . *0 ),
H " $
H ; I $
H 7 ! $
I
H ; $
I
H 7 - * 1 ),
I
H 6 - ! ! * ),
I
H 6 - !! $
I
H 6 - $
I
H6 $
I
H * ),
H " J . * ( ( ),
H " ? J 1 *1 0 ),

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 99


The profile of prescription................

!( ! 3
. ! 0
!

&' <( & 3 3 0 - & * + ) 33

& 3
3
* +
3
* -
* - 5
3
$ &
0
1
' .
1
&
' & 3
67
0 +
- 3
(
3

&' =( ! & 3 3 * - *

" 0 3 3 9:;
H? 1 *1 0),
H 1 *1 0),
H? . *'$ .),
H * 1),
H 3 && *.1 0),
H; - ' * & '),
H6 $
H * ),
H * ),
H7 ! $
H $
H; + $
H - $

! 0 ) : !
: - ! !
;
4 A

100 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Umi Athijah et al.

! 1 0) 62
62 !
F 9 !
- !
- ! @

- * , ! -
* ,
! -
& ')
7 ?

! - ! -
F ! - F
*6 $$(, 7
F *2 $ $, ; !
- !! ! ! *? $$#,

(! % & '
! &. *..), !
! ! ( ! !

&' 6( > 3 * - ! % & ' 9 ?7<;

> 3 9:;
H &' *#1 .),
H6 & *# ),
H6 ! &. * $$),
H6 * , 1( *(& 0),
H> *' .),
H & *( #),
H ' *&0 ),
H6 " . * $ 0),
H *'$ , & *( #),
H; * , *' .),
H 8F * (),

! *68 98 5 $$1,
6
! F
5
!
" 3 * $$0, 7 - !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 101
The profile of prescription................

- ! !
* $$',
! !
*5 $$0, 62
($4 $$ + C
* > - $$., ! 62
4 3
62 3

" "% )
! !
! !
4
!

" >% ! #
A
K

@ " )
6 $$# 6 B 6 2 ' *
, . 4 .0
5 5 L? > K $$0 8 B M C
4 6 2 ! B
/ ! "# $ .# *1, & #4& 1
5 L C 7 2 $$' 9 !
*9 , 6 2 9 - 9
2 A % & ' * , .4 .
> - L F $$ $' # "# '( ) # &
C > -!
68 98 5 $$1 * & * # % +,-.& / .$*. 0.,++1
$ " ' * /
68 98 5 $$. " " 2 3 3 D - 6 -
> 9 9 - 6 A > 9 9
6 9 5
6 D 5 C N K B 2 @- K 5 ; > K L C 2 $$(
"# # '( " # #' # ? !N - 2 K !7
2 ? N LN $ $ 6 5 ! %
6 * # $4 05 6 D -
? N N L? K $$# % %
2 - * # $4 5 6 D -
> - $$. * " " # & ,

5 - $$# " " # 7 / % 8


" / 9 *

102 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Umi Athijah et al.

7 L9 $$# 5 ! B
2 B 7 # $ "# '
& *', #04 $
7 L 7 $ 6
! - 3 I &
: #
5 2 D $$0 "# / # " ( ) "
C ; L; -
; 2 ? LK $$. !
!"" 1 ('4#'

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 103
Victoria Yulita Fitriani et al.

!
! " #
# $ "

" %&
' (' )*+* , ! !
"
" , "
-&. // 01 ! 2
-+* ) 01 -+3 .. 01 -3. )4 01 5 -% + 01 6
-) % 01 7 -) % 01
5 -) % 01 #
! $ 8 ! -9:;1 "
7! " /& /*0
! !
$ 8
! $

"# $%&' "%#


" < = : = , 6 > ? -=@,6>?1
!
! -9:;1 ! " =@,6>?
! ! 9:; !
!
# ! ? !
!
! - ! 5 ! 1 - ! 1
- ! 1 - A B ! C
)**41 " !
! ; !
: !
! $ ! !
5 5 ! ?
! !

104 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Identification of antibiotic use..............

!
$ ! = $
! D 79 !
! ! , $ ! ! !
!
? $ ! !
- )**&1 "
! ! !
-<! )*+*1
"

( )%&%*%+
&
" E C

,-
: ' ' )*+* ! +F ( 3F !
! ! !
" !
2 ! ! !
,
8

$ &
%& 6 %) & 0
F4 +0 ! ! F ! %3

" -&. //01


! 2 -+* )01 -+3 ..01 -3 )401
5 -% +01 6 -) %01 7 -) %01
5 -) %01
# ! $ 8 ! -9:;1 "
/4 /*0 !
! $ " 7
-" +1

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 105
Victoria Yulita Fitriani et al.

" + $
< : # ! , ! ; ,
D;: 9
+ D % F . F** ! ) F** !
. F** ! ) F** !
. F** ! ) F** !
. F** ! ) F** !
) D + F . +! ) +!
. D + F . + ?G F** @ +)F ! # +) ( )%

; ! !
!
$
5 - )**41
"
E "
/4 /*0 +) )0
! !
! ! # $

? !
" ! !
D ! $ D
! ! 4*0
! .*0
-9 )**41 , ! $
- ! F1 ) F** ! @ ? "+@)
; !
, ! 3( (/
4F % H@7 F 30 , ! !!
-C +&4&1
$ %*
( 3* 0 ! !
I
! ! ! - B D )**&1 "

7 ! 7 !
- )**&1 D (
- 1 8 3* 0
%*0 ! ?
4 )* ! $
- B D )**&1 ! $
7
! -< ! )**/1

106 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Identification of antibiotic use..............

! $ ! ! 5 !
! " :
, ! ! ! ! D 79 :
! !7 !
! ? ! ?
$ ! ! "
! "
!
!

%# *' "%#
" 5 !
! ! !
$ ! "
$ 5 : !
!
! $

$( ($(# (
D D )**& " ; C ; ! = !
+)F74/
9 9 < ; J )**4 : ! " J 0 ,
: ! " : = ? '
< ! D )**/ , !7? < : I4/-3124%.74F*
<! "G )*+* " ? ! = ,
)*+*I.F-.12C +37C )+
A C , !, ! $ 1
: )**4I4F2+%/47&3
G J ? < ; )**& !
? E : ?@,
D ! C '? )**&I +/2 +*/7+.
D )**& 2" D , !; .3
)+/7.4
C 9 : ' 9 +&4&
$ D )F-%12+/&7&F

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 107
Rochmy Istikharah et al.

" # $ % &" %'


( # # ) * + ,,-. //-/0
+1/23. ! 4 5 # # 637 ) 8
4 ! ) 9
! :8 ; ! : " % 8 + ,,-.
1,/6//2 /3 333 * : # : ; &*.9"' !
8 8 " % 4 ) 8
& ' *.9" ! 8 ) <!
" % 8 + ,,-. 8
) 5 8 8 # 1/ 8 !
! ) . 2)= ;# *.9" ! ! 1$ 9 3
4 ! 8 > ) 8 ? 8
8 8 # # 8
" % &@ ,3- .A+') 8 ! # > 8
! # 8 " % & B3)3= $ 4 '
%* ) ( !! # 8 !!
)
" % ! * :
# : ; &*.9"' !

! "#$ "!
" # $ &" % 5 =1=333'
( # # )
%. & %.'C +1/23. //-/0 + ,,-. 8 " %
& 8 ) 66 ? ; 8 66 ? D ) 6--') 8
) . 4
=37 37 8 # ! ! %.
! 8 4 )
# &* ;; 8 ) 332' !!
8 !
)

108 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Identification of the variants..............

9 * ;; 8 ) & 3 3' 8 %* ! & 1,/6//2


/3 333' 8 # 8 " % 4 # ; !
) 8 & ' ! 8
4 " % )

%& '"#" "()

* +,
" % ! 8 ) .
" %: # 8 4 # : ! )
E ! $ 4 8
# ) . 8 ! # : !
# %. " % ) . #
8 # 8 )
E 8
8 8 ! ) #
+ ,,-. %.) <
8 ) 5 8 ! # 1/ 8
! ) : ! 8 @
* ;; 8 & 332' 8 8 " % ! )

#! - .- / * 0
%. 8 8 # ! F
) ! 8 8 < # #
! > ! 3 ! 4 8
! ; ! 9 > ! %0 5F* : ". ) . 8
( 8 ! . ( # 5 ! )
=3 G *09 8 8 !
= 6= 0 8 # 1= 6= 0 13 !
13 , 0 ) . 4
8 , 0 3 ) *09 8 !
H5.> ; *09 0 : I ) %. 8 ! 5 I #
> ! ! > 1,13J" !
8 *09 )

* - -
! > !
" %8 ( ! $ 4 &8 : ' !
K 3)3=) 8 ! 0 8 )

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 109
Rochmy Istikharah et al.

&*$ * !# # * $** "!*


=1 " % ! - !
8 1/ ! 8 4 )
! #
# # ! ! # ) " %
! 8 " %! , ) 7 )
! 8 ! )
. 4 2)= ;# ! 1$ 9 4 !
8 > 12 ! - " % -
" %)
! & %* ' 8 ! 0 #
! %. > 8 > ! )
%* 8 & # ' 8 8 8 # #
@1 - 0 & ' @ ,3- . + & ') 8 8 %*
! : 6, + 0 : 6 0 %* !
; 8 %* 8 %* 1$: 9) D 8
%* 4 ! ) @/ //3 0 4 2 !
8 4 , @// 11 0 + ! )
> !
! 8 & # ') # 8 " %
" % ! # > 8
! $ 4 &8 : ') 5 4 # $ 4
! 8 ! 8 ( ! ! 8
! & ' 4 " % ! #
) 8 8 %* 8 !
# 8 " % " % !
# > & # ') . ! + > 1,/6//2 8
! # 8 &-1)117' " % &26)//7' 8
! ) + /3 333 8 ! # 8
" % &-3)117' " % &,,),-7' ) 8
@ ,3- . +8 1 & L 3) 16/')

"! $* "!
5 8 ? 8 8 8
# # 8 " % &@ ,3- . +')
8 ! # > 8 !
# 8 " % & B3)3= $ 4 ')
! # ( > )

!" &#(&%&!
D ; ) I 8 4 ) D
! " % ; ! # )

110 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Identification of the variants..............

+- 1 %* ! # 8 " %
!
2 -
! +*! # ( . -- -
# + 3 0

) 1,6 =-- +: 6,0 * )3333 3)- 12

) 1,6 =-6 : 6 0 * )3333 3)- 12

1) ; 8 01 - 5 )3333 3)- 12

/) ,/ -2 3- + 2/2 . 5 )3333 3)2,1,

=) 1,/6//2 + 2213. 5 3)23 2 3) 22-

2) 6=1/ 6 2,=30 5 )3333 3)212=

,) ; 8 . ,3- + 5 3) -2 3) 16/

-) /3 333 + ,36/. 5 )3333 3)=262

6) ==/16, . --=+ 5 / )3333 3), 3

3) 1- , = /31=6+ 5 / 3),11 )3333

) ,2= 31 / 1/1. 5 = 3)23 2 )3333

) 136 0/ //3 <4 2 3)23 2 )3333

1) 212- 2 0//3==+ 5 2 )3333 3)- -

/) 1,1 =- 0// 11+ <4 , 3),11 )3333

=) 13=222 =363 + 5 , 3),11 )3333

2) 2 66- += = . 5 6 )3333 3)1=,3

,) 21331 .==2,3+ 1$ 9 )3333 3), 3


8 ! $ 4 &8 : ' -
" %) 8 ! : K 3)3=)

&3& &! &*


8 % ". 0 ! . I # ; 5 * M ; ) 66 " #
C % 4
! . M + /6&=' 616:=3

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 111
Rochmy Istikharah et al.

D 0 ! + " ! M. + " (( . ) 6-- %.


8 " # N / &/--/' / ,:
13
; 8 % 66 . " # ( #
# ! ! . M +
= &2' -: -
* ;; 8 % 0 ; !; 8 D" 9 ; * ! 8 !
9 ! % ) 332 > " #
C 13 + ,,-. ! M + = &/' 6-:13/
* ;; 8 % I ; M 0 ; !; 8 D" 9
) 3 3 + :8 ; ! *.9" 4
" % + -& ' 16:/6

112 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Fef Rukminingsih et al.

! "# $#

% ! ! & !
' & ! & $
( ! & $ (
! ! ! ' ' !! ! !
! & ! '
& ! & "# )
* %! + $ , ! ' ! '
& & &
! & !! ! ! ' ! ! & ,
! -.$/ 01 !! ! ! ' !
! -,$2301 !! ! ! ' ! 3
! -4/$2 01 !! ! ! & ' ! $ ,
! & & ! - 3 +01 & ! ' / ! - .+01
& ! ' ' 3! -3 $. 01 & ! ' 55
. ! -. $4301 & ! ' ! -,$2301 & !
! - + ./01 & ! ' ! -, 2301 & ! ' '
& $

6 0 $#$
! ! . ! ! /+ ! ! & & $ '
& $ ,/0 ! & !
' ! -6 ++21$
( ! ! ' !
' ! ! !
& $ !
! ! $
% # " ! 7 8 6 9
( : ; ' ! <' ! '
+=4+ : -6 ++21$
( ' ! ' ' & !
& ! ' $ %!! ! ! !
! ' ! $>
' ! $ > ' ! !
! $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 113
Evaluation on the therapy.....................

% & ! $
& ! & -? +01$ ( '
@ ! '
! ' ! & !!
! -: .. 1$ ! 4*
-; ++.1$ # ! $
) ! !
! $( &
3+ ! $ ! ! ' !
$ ( ' !! ! !
! ! ' ! &
$

! & & ! ! ! ' '


!! ! ! !
& ! ' & ! &
' * %! + $ !
! ! ! & & 5
A A $
# , ' & ! & ' ! &
"# ) ' B%!
+ $

, ! ! ' & &


! -/,$2301 & ! .! -,/$ ,01 &
.! -. $4301 & ' ,+ ! -2$ ,01 & ,+
/! -/.$/ 01 & & 2! -,+$,401
& $C !
! / $( A ! & .! ,/$ ,0$
! , * + ! !
! ! $ ! /B3
! / $ 40$ ( 4 , $430 ! !
$
( A ! ' ! & 66; %>>"% $
( ' & +! $4 0$ % A ' &
66; %>>"% 6 D % & & 4! .$+/0$
( & ! -,$2301 ' ! ' $
C ,+ -./$ ,01 ! ! ' ! $
% ' ! ! ! &
, ! ! ! - +$./01 ' ' '
! 2 - 3$3201 ' !! ! ! ! 2
-3,$ .01 ! $
9 !! ! ! ! & ! & 6)
! & & ! &
!! ! ! ' ! ! & -+01$
( & , ! .$/ 0 !! ! ! ' !
! ,$230 !! ! ! '

114 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Fef Rukminingsih et al.

! $ C 3 ! 4/$2 0 !! ! ! &
' ! $
; 8 & & !
- 3$ +1 &
/ ! - $.+01 & %69> 3 !
-3 $. 01 & 55 %>>"% . ! -. $4301 &
66; ! -,$2301 &
; ; ! - +$./01 & ! -,$2301
& & 6 D $

; ! ! , ! & ! '
& ! & "#
) ' * %! + E
• % ! &
%69> - ! ! ! ! 1 %>>"% - 1 66;
- ! ! 5 1 ; ; -' ! 1 6 D - 1
- 1$ ( A ' 66; %>>"% - $4 01
& A ' & 66; %>>"% 6 D %
- .$+/01 & %69> 66; - ,$ .01$
• % ' ! ! ! &
, ! ! ! - +$./01 ' ' ' !
2 - 3$3201 ' !! ! ! ! 2 -3,$ .01
! $
• : ! ! ' & ! !
! ' ! +0 ! ! '
' ! , ! ! -.$/ 01 ! & ! '
' ! ! ' & ! -,$2301 ! & !
!! ! ' ! 3 ! ! -4/$2 01
• ; 8 & & ! - 3$ +1 & /
! - $.+01 & %69> 3 !
-3 $. 01 & 55 %>>"% . ! -. $4301 &
66; ! -,$2301 &
; ; ! - +$./01 &
! -,$2301 & & 6 D $

% 6$ ++3 " : 9B; $ +- 1E 7


! # % $
6 )$F$ ++2 ' > C 6 )
$ / .+B.2$
$ ++2 ( : ! : 6% !
,E 2 B 2,$
8 ) E ) GH> ++ 6 6 ) E
9 6 I# .$
8 ) +++ : ! ' 9J 6 C !
3E3,3*33 $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 115
Nirmala Manik et al.

" # #$ " $
%# & $ "
& " # ' " # $
( )# * ( )+ " #
! , " # # -
$ , , # , # ,
, - ./ # #
# ( )# * ( )+ 0 1 , "
# # #
# , " %# /,/ 2 * 3 / /4+ &
$ # 5 # %# &
" %# 6 # , , #
, # , , # %#

" #! "
( " # $ $ # " 7
, # # $ , $ #
$ # * # 8 , 229+ " , " #
$ # " # # " # ,
$ " # , # #
* , //:+
6 # # $ $ #
# $ # , , ,
, # #$ 0 , " #
, # , # * ,
//;+
- " " $ !, * 0
+ 7 " <$ ! $
$ 6 , " " # #
$ 7 " < $ ! #
* =& , //9+
> )# ( * >)6(+ $ # 5 5
# #
* 8 ! , 22;+ # %# #
"

116 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Evaluation on quality of...............

? # * 222+, ( )# * ( )+
%# #," # #
, %#5 "
& ( )# * ( )+ # #
> )# ( * >)6(+ "
& ( )# * ( )+ 2 %# @
A
?$ A $ $ , $ , $
- # A 7 # , " , " , ,

. B # A 7 # , # , $ , # , " ,
$ , , $
: A$ , $ , # , # ,
4 ? A # ! , $ ,

@ C A $ # , "
" ," " " ," "
$ , $ # $
1 ## , # $ # ( ) # # # #
" $ # # & $ ( ) # #
" " $ #
$ #

$ %" "&"'(
) * )+
& # $ " * =
# + & # $ $#
%# #
!

) * *
& # " # 1 6#
! # - $# / # ? /

) * , *)
& # # " " " #
# ! & " # ./
" #
& # A
" " $ $
# !

" $ $ # &
( )# * ( )+
& 7 # A

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 117
Nirmala Manik et al.

" " # " $


# %#
"
. " " $ $ , $ ,
#

) * - , )
& $ A
$ A %# "
- $ A 5 * , , # , # +,
*$ # 5 +,
* " # , D +

". ) / )
( " # $ $ # " #
# # =# &
# " # $
E
)# # E , #
# # " # ,
"
. & %# # $ %# $ " $
# " $ # , $ # #

: %# * ( )+ %# $ #
* 222+ " 2 %# , 7 , A
• ?$ A %# # $ ,4, 9
• - # A %# # $ ,:,;, , .
• A %# # $ .,@, , ., 9
• ? A %# # $ 9,2, :
• B -# A %# # $ /, , 4, @, 2, /, :, @
• C A %# # $ ;, , 4, ;, 2
4 ( )# 1 (
)# * ( )+ $ # * 22 + " $
0 1 # # 1 1 %# ,
" , 9 $ " * %# +, "
# " , * +B ,* +6 , *.+ > , *:+ F
@ ? " %# " A #
" G G, # " G G, # . "
G G # : " G G
9 & " G G" %# .
" ! , " G G %# " !
; " # "
" # ( )# * ( )+, " # "

118 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Evaluation on quality of...............

# , - $# / # ?
/
2 & # $
# , " , ? "
, 0 #

/H # #
# # # # 1 # %#
# %# $ %#
# # $ # ,
# $

* ) /)
? $ # " #
#$ 5 , " $ %# H "
# # " * # #$ + $ #
# $ # # %# ,
" " $ # #
%# %#
& # " # C # ' #
# " #
0 ! E , "
%# & " A
# #$ $ # 7 #
$ ,$ 5
. # %# #
%#
: A
# A
( )# 1 # #
, " # " G G, # "
G G, # . " G G # : " G G
- , " # $ # 2= @ #
& %# $ $
& I # $ " $ #, 7, ,
# , " %# , "
$ # # *?F6H?+ & "
3/ /4 & #
* + 4/
4 # # # !

$ #& !# "
& # #$ . *9@ 9J+, * . .J+ 0
#$ , " # / :/ 4
* @ 9J+, : @/ ; *@/J+, K @/

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 119
Nirmala Manik et al.

9 * ., .J+ 0 # , #$ 5 #
# 9 * . .J+, #$ "
# # # . *:. .J+,
# $ / *.. . J+ & #$ " #
# 4 * @ 9J+, # =
4 *4/J+, # 4 4
* @ 9J +, #$ " # " #
4 4 * @ 9J+ L ! ! #$ !
$ $ " #$ 5 $ $ $ "
1. & $ #
1 , #$ " # $ &
" $ # # # ' "
$ # $ * $# $ #$# , $ +
$ $ 7
7 > #$ " ?
/ *.. .J+, 0 2 *./J+
*.@ 9J+ & $ $ " A

& $ & #$ 5
) , * )0 * * ) *) 123
?
/=:/ 4 * @,9+
$ : =@/ ; *@/,/+
K @/ 9* .,.+
7
.*9@,9+
$ - 9 * .,.+
B #
B 9 * .,.+
$ *M# N .*:.,.+
+ / *..,.+
* $ +
# ( #
3 4* @,9+
$ = 4*4/,/+
K =4 4* @,9+
K4 4* @,9+

& $ .& $# #$ $

+ / ) ) ) 4 123
? / *..,.+
0 2 *./,/+
*.@,9+

120 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Evaluation on quality of...............

&
1 " A
F# $
& & &

* + D # DB ( 4
* + D D B 9
( 2
*.+ D # D D 9
B (
*:+ D # ," # B (
*4+ D , " # 4
B (
*@+ D # D , " # :
B (

#$ " " 7 $ , "


?? ( # , #
$ , 7 # = <=
$ ! # $ * =& , , //9+
- # , # #$ " " # A
" " # ,
# " $
B 0 ( *B0(+
1 # "
2 *@. .J+ " #
*.@ 9J+' $# $ & $ :

, 56 ) , / ) * ) , * ), ) . ) / .

. ) / . 123
D 2 *@.,.+
" # *.@,9+

7 / /
)# " # " %# "
$ # # 222 & %# 2 %#
@ $ , # , , ,
# , 7 , $ 1
%# # " # $ #
* ! +" # O / /4 & #
# *?F6H?+, " " "
$ & " # $ "
" # & # # , # # $
$ $ # $ %# - ?F6H? ,
" # $ # * +, $ " "

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 121
Nirmala Manik et al.

$ " # 1 # / /4
# , #
/ /4 #

6 +
# " , #
# , $ , , ,
%# # #
7 $ " %#

& $ 4 & %# " $

+
/&/ 8 9 58 5 9 <8 > <8 + /* *
7 ( ) ( ) ( )
1 : ;3 1 : =3 1 :?3
?$
9 / ; 2: / : / 22
*? +
- # *-?+ @/ ; ;. / 49 / /24
* + @ / @ // @ :. / 2/
? *? + 2 / ;9 2 :. / 94:
B -# *B-+ 4 ;/ 2: . ;@ / .4
C *C6+ 9 :/ 4 9 49 / /2/
* ;9 :/ 92 @9 ;; // / 9@

1 , # " %#
" - & $ 4, " # %#
# / 9@ * K / /4+ 1 " #
#
1 # , # " , $# %#
# @/ " $ # %# #
# & $ $ $ # , # $ @/ $
$ " 7 , $ ' "
$ " #$ #
%# C $ , 9 # #$ , #
# $ @/ , " $ " ? ?
" , $ " ,
! $ # $ @/ $ # %#

6 @
- , 7 %# , #
# " 5 %# $ 5* $ @+

122 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Evaluation on quality of...............

& $ @ & %# " $ 7

@
/&/ 7 + / *
) 1 : A3 B ) 1 :?3
?$ *? + ; ;9 2 : /; :
- # *-?+ / /: ; 49 / ..
* + @ .2 4 2 / :
? *? + ; 2@ 2 // / 2@:
B -# *B-+ . :. / @49
C *C6+ @ 9 @ // / ;;2
* ;. @4 ;/ :. / 4./

- $ @, $ # %# #
/ 4./ * K / /4+ & " # $ "
#

A6 $ * & 4
1 # , I " # %#
"

, ?6 C / / / . ) 4 * )), ) *

$ *
/&/
$ * %+ + / *
7
1 :?3 1 : A3 1 : 83
?$
@ :. 2 ;4 2 4/ / /9;
*? +
- # *-?+ ;9 2 /; / / .
* + 4 // @. @ 9/ / :/
? *? + ; 2 2 .; ; 2/ / 49
B -# *B-+ 9 .. . @/ /@ ;
C *C6+ : :. @ @2 @ @/ / 2/
* 9: 49 ;: @ ;@ 4/ / /;4

& # " $ " #


= # , = # = #
* $ 9+, " # %# / /;4 * K / /4+ 0 #
, $ # #
%#

56 / ) )
1 # , I " # #
%#

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 123
Nirmala Manik et al.

& $ ; & %# " $ #

/ ) )
/&/ 9
D ( ) > E; >;( ) +
7 ( )
1 :;3 ( ) 1 :;3 1 :;3
1 : ;3
?$ / ;/
2 // 2 . 2 :/ 9 ;/
*? + @
/:
- # *-?+ / @/ 2 2. 9 ;/ / //
;
/ 42
9 / @ // 4 :/ @ /
* + :
/ @2
? *? + 2 ;/ 2 /9 ; / ; @/
9
B -# / :/
4 ;/ @/ ;/ ;/
*B-+
/ :.
C *C6+ @ / @ ;9 : @/ 4 :/
:
/ 4/
* ;; @/ ;. @/ 9; / 92 ;/
;

1 $ ;, $ # %# #
" # , = , K =4 K4 , / 4/; * K
/ /4 + & # & #
# # %#

;6 + / ) ) 4
& # # $ " #
" , ?, 0, &
#$ $ # , "
$ $ $ E

<6 , F6 C / / / . ) 4 * )), ) +
/ ) ) 4

+ / ) ) 4
/&/ ! )) ! )) ! )) ! + /* *
7 1 : 83 1 :F3 1 : 3
?$
2 ;/ ; 4@ ; :4 / :2@
*? +
- # *-?+ / 2 ;2 ; ; / /:

@ ;/ @ .. 4 .@ / 92

124 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Evaluation on quality of...............

* +
? *? + / / ; :: ; 9 / /;:
B
. 4/ : :: :4 / .4
-# *B-+
C *C6+ 9 ./ 9 : 9 // @
* ;; ;/ ;: 9; 9@ // / / 2P
P 3 /,/4
- ?F6H? , "
# ?, # 0 # ," # %# // 2 * = #
3/ /4+ & $ # 5
%# * $ $ 2+ 1 # %# "
? 0 ," " %#
# $ & " # "
, " # %#
- # &#! E 0 , $
# ?, 0 1 # %#
? # %# # *
3/ /4+, " %# # ?
# 0 * K / /4+ # 0 #
K / /4+, " $ $ "A

. 6
+ / ) ) 4
- , //6 $ +
& ( &#! E ? E 0 :/ : ;:;22 @;;
)#
E ;//// :@ 4 / @P
E 0 E ? =: / : ;:;22 @;;
E ; 9999; : 9:.:: 9.
E E ? = ;//// :@ 4 / @P
E 0 =;9999; : 9:.:: 9.
0 E ? E 0 :/ : ;:;22 //
E ;//// :@ 4 /./P
E 0 E ? =: / : ;:;22 //
E ; 9999; : 9:.:: @
E E ? = ;//// :@ 4 /./P
E 0 =; 9999; : 9:.:: @
P 3 / /4

1 # , # %# " ?
0 , " " %# # $ ,
? & " #
" , " # %#

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 125
Nirmala Manik et al.

?6 . ) / .
1 # ," I %# "
" # , # "
# *B $ +

=6 , 86 C / / / . ) 4 * )), ) . )
/ .

* )G&+ * ) &+ +
E E
/&/ G G% G G% G G% G G%
7 1 :;3 1 :?3 1 :?3 1 : F3 1 : 3 1 :;3 1 :53 1 : 3
? /: 2 2 ;: 2 .9 /4 2 4 ; ; / @9
-? 2; 2 49 / @. / ; 2@ 2 2: 2 ; / :4.
. 4: 4: 9 4. @ 44 9@ 4 :: @ ; /2 4
: ? 2@ ;9 ;9 2/ 24 2 ; /. ;2 /2 :
4 B- 2; . 49 ;: :4 4 / .; . .@ / 9.;
@ C6 @: @ 9 /2 @ 4. 9 @ . 4 4 :4 /. .
& (
)# ; : ; /@ ;; /2 =A6=5 ;4 ;@ ; 9 2; = 6 ? / 4@;
F A
O
O #
O

- , " $ " "


# , # O / 4@; * K / /4+, $
# %# "
, " $ /
# $ " " " " # #
! & #
# # $ *? , // +

!" !&# "


1 # , $ # $
# , %# " & ,
" # %#
- , 7, # , # # ,
, 5 %#

$B$ $ !$$
? , 0 , // , # & 6 ? # A
& , , ;*;+, 494=4;4
0 ! , >, 1 , B M , ///, )# ( # (
, :9,:::=:4:

126 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Evaluation on quality of...............

M?, !
0 , 22;, , ( => ,
, =49
- # ,? ,0 # " , B, L , (, # , (,( , (,M , M(, ( I M , //2,
, 9 , " , 9 = 9:
=& , , ,? M , ,F , ,C , //9,
H H ,? ?
# ( *?? ( + # , ,:@*.+, 2 2=2.4
, , , , # ,? , Q , C , // , = AB #
$ , ..,9.9=9:@
# , MM, , > ? , 0# $ , MMH, , ? B , //9, 6 " >
=> )# ( " ( ,
! @4*9+, 9= ..
# , MM, , ? , M , (, , > ? , //;, B =
> )# ( # A > &
" ( , " , 9* +, 24= /4
# ,? , , MB , 229,# $ % & ' $ ,? $ 1 " , , B ! =2,
$ 0#!# ! ! B
L# MM, H 0## , > , , > ? , //9 ? A ? > "
! , @4*;+, ;.= ;;
,? , , , # , (, L !, L , //:, ,
, ((() ) *) # / //9
F# , //@, + , 0#!# ? 1 # ! ,B ! =:, M , #
$ 1 =-L 1, M ! , ::.=::@
, , // , + $ $ ' $ + ++, & B 7
L # ,M ! , /.= .
,1 , //4, + $ $ $& , # ! " , /= @
, M ,& ,B , , M M , //;, ,1 A ,
M&, & $ >(, , , I! , >, C , 0 , , ( *B +,
, , 9 , "= ,
1 ,F " !, @..=@:;
!, , ,M , 22., * # + , 4 , 0 !"
#$ ,( , : 4=:.2
& , 6, $ , - , //2, 1 A L =L $ , ? , # , ( , ? ,
0 L, , > $ (, # ,0 M ,L ,C ?, C ,0 >,
, - . ,2 , ( C 8
C ! , ;
# Q , # ,L" ,0 F, L , 222,
)# # > )# ( " (
, ,:4, 24=.//
Q#$ 0 - , ?>, ? ,) > , L# > , //9, %#
" # =
%# %# , !) / - // / , 2* +, 9=

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 127
Didik Setiawan et al.

! " ##
$ ! % & '

$ ! ! ( ) ( (
( ! ! ( !
%!! ! ( ! !
! ( ! * ( !
( ( ! !
( ( ! %$
( (
! !
+ ! ! ! , -./ /.01 ! %$
( /2 -// ..01 ! ( ( ! /3 3,
$ ! %$ ( ! ( -.+ 41 ( !
( ! ! ( 5 -64 41 ! (
( ))7 -.6 01 ( ! %$ (
))% ))7 -6 401 ( ( !
%$ ( !
$ ( ! ( !
( ! %$ ( ( !
( ! %$ (
( %$ (

7 ! ! 7
! ' ! 4 ++ +++
! ! /. ++ +++ ! ! 7
! 8 $ 9 ! : ; ++36
' ! ! ( ! (
! ( ! (
! ( ( ( ! !
( ! * ( !
( 8 $ ! $ 8 -8$$81 $ "
* 7 $ ( ! (
! / % ( ( ! %$ -.5
( $ ! ! 1 ( $ - ! !
.5 1 -*'1 - '1
-<<& 1 -<<& 61.
( ! ( !
%$ - ( ! ! 1/ (

128 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Cost Analysis of Early Stage ………….

( ! ( *' -9 = < +4 1 ' -9 = < +4 1 5


( !
* ( (
! ( ! (
!! ! ! ) ! ! (
> ( !
3
( ' (
4
! ! .
2
! ! ! .20
! ! ! .0 ,0
? +! ( !
@ /6/ ! !
! % A !
( (
! ( ! ! ( ! %$
( ( ! !

(
! ! !
(
! ! !
! ! ! + ( + +
( +

!" #$% !&


! ! ! !
%$ ( ! ! (
( ! %$ % $
! B ++4 ( 4 +
- 1 ( - 1!
! ! -61 ! ! B ++4
' ! ( 6+ + + ! - 1 ( %$
( ( ! - 1 C !
> ! ! !
" # % = (
! - %$ ( 1
$ !
! = ! !
D
!
!
A ! !
! !

#'&
&( )& !" !& ( &(!
! ( !
%$ ( ( ! # ++4 ( 4
+ +! ' -./ /.01 %$ ( !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 129
Didik Setiawan et al.

E
/2 -// ..01 ( ! ! -
E E E E E E E
' % = >( 1 -7 1 (
( ! ( ! ( (

( $ ( ! ( (

!" # $%&
%$ -.5 ( ! ! 1 , -.. /.1
/2 -// ..1
- %$ -! F ( ! ! 1 -+ 2 1
- % -! F ( 1 66 -6+ ++1
- $ -! F ! ! 1 . - 6 ,/1

) ! ! % -! F ( 1 (
( $ -! F ! ! 1 ( ( (
( ! ! %$ -! F (
! ! 1 ! %$ (

( 7 !

# ' $!( )& * $!(+ & , $!(-.&


% - G' 1 /3 3, G 2 4 /4 ,, G 2 /+ /, ,/ G 4 42
> -01 H
- .+ -/. .1 6 -. .1 4 -6, 31
- " /3 -/ 31 4 - 2 .1 2 -.2 1
- 8 6 - 41 - 4 +1 -/ 1
> ! -01 H
- 9 . -/3 61 6/ -.. 31 4 -6, 31
- 2 - 3 61 + - , /1 2 - 4 /1
- $ - 2 1 / -, ,1 3 -6/ 31
- * 4 - , /1 6 - 61 .- + 1
' -01
- + -2 31 .. -2+ 1 /3 -2. 21
- ' 4 -3 61 , -2 41 -/ 1
-01 H
- 8 5 /, -/ 41 3 -// 61 2 -64 41
- /2 -// .1 6 -.+ 41 4 -6, 31
- ! . - 6 ,1 6 -/ 21 - / .1
' -01H
- ) 3 -, /1 , -2 41 - +1
- ))% 63 -66 ,1 + -6 41 3 -6/ 31
- ))7 /, -/ 41 + -6 41 , -.6 1
- )))% +- 4 1 . - / ,1 .- + 1
H

! /3 3, G 2 4 ( !
! 4+0 ! %$ ! !
! > ! ( ! I
. -/3 601 ! ! )C 6/ -.. 301 ! %$ ! 4
-6, 301 ! !

130 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Cost Analysis of Early Stage ………….

) ( ( 2+0 ( !
%$ ! %'A>'
B% '*' >A ( ! ! ! 5 -64 401 )
! ! ))7 -.6 01 ( %$ ! !
))% ))7 -6 401

)& * +( & ,#&!,*


! %$ ! (
! J*' ! ! C
( ! D
! ! ))% ))7
! ! J*' )
! ( ( ( ! = !
( ! ) ! !

( 6 J * ' -J*'1 ( ! ! !
- 1
* ,
/ ' # 0 '"
/ 1 / $ &
"2 - 3 1 43 4 )1 5 ) 56.
- ' ) / 3 G + 24 6 ++ G + ++H + ,6
- ' ))% / 2. G 4. / .2 G 43 +3 2
- ' ))7 / /+ G ,+ . 6 G 6+ + /,
- ' )))% . ++ G 6 , ,+ G . + +,+

3- 1 4 .) 15 3 ) )))
- ' ) , 46 G ., ++ G + ++H + 3+
- ' ))% 3 /+ G ,/ 2 ,. G 6 .3 + ++6
- ' ))7 3 ++ G /3 4 4. G 2 + +++
- ' )))% 4 +G /6 3 /+ G 6 +2 2

' 415 3 - 1 5 36 ) ))
H# !

! ( A ! ) (
! ( ! (
! ( ! (
! ! ! %$ ! ) (
! ! ( ! (

, & ,- & &* )&


% ! %$ !
! ! (
(
( ! ( !
D ( %
( %$ ! ( !
- ! 1 ! =

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 131
Didik Setiawan et al.

A ! ( ! !
%$ !
( / ! ! $ ( !

0 2 $ " " &


0 '"
* % , %
56 ) +5 34 ) . ) +)
2 # " 57.)3 ) . -7 4 -- ) -+4
- $ .6 ./
- % ! 42. 42.
- ) 3. 346
- .62 3
- < 2 6
# '* -7-3) 33 +7)- + 3 ) ))
- 2., +,
- +66 ,32
- 8 63, /+,
8 '9 7)45 4- -73 . -. ) )))
- ' .2
- $ ! 26 .3
/ ' +7) 4 - 3 676 6 . 45 ) )35
- ' +. ,3
- < ! / 2,. , ,.
/ 7 .6 . 34 + 7 4) +- +) ) )))
- ' 6 . 63 6
- $ ! , 32 .. 3 4
- 5 ! 3., 644
- 5 ! 2 ,+
- < ! +3 ,+
537.6 )) )) .+75+4 )) )) ) )))

132 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Cost Analysis of Early Stage ………….

! ( ! %$
! ! %$ !
! ! ! ! ! ( -.3 4601 (
%$ ! ! ! ! - 2 +201

( !# (,)
$ ! ( ( !
, 6 / .
%$ ! J *
! ! C
! %$ (
,
( %$ ! ! %
4+ /0 ! %$F >$ ( ! (
,
( ( ! %$ -. 601
! %$ !
( ! /3 3, G 2 4
,
% ! /. %
3
( ( ! ! ! ( (
! ( ' !
6+
) 2 30 !
' ,+ /0 ( ( (
) %
( ! ))7
,
% ) , 20 ! ))7
(
(
7 ! ! ! ! !
! %$ ! ( 7 !
2
" C ! 3 63 464 / ! ! !
3
! ! -.. 3 4 62 ,. ! 1 +
! %$ ! -, 32 .26 . ! 1
2
D = > $ ! 7 ! ! 3
%$ ! , !
$ ! ! %$ !I
2
D = ) > !
/23 4 / ! %$ /+. + , ! ! !
( (
( ! ! !
2
%$ ! ( "
( !
! ! !
! ! ! 7
! 5 !
! ! ! !

(*(& &(,) ,- &" &#+.


$ ! ! # !
! = !
! ! = ( !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 133
Didik Setiawan et al.

! ! = +! !
# ! ., 0 ! 4+0
! = .+2 !

> ( ! ( !
! %$ ( ! ( !
! ! !

$ 7 5 $ J ! = % $ B J ++
D9*
> 7A D > A 7% > $ K ( %" % <8 B % ' B
J !5? ) ' J$ 7 # " 'J < J%" + + %
< ! 8 ' $ 23.5 ++, $ $
) ! ) -< ' 1 < <
!" " ,& .//5.36
% ++2 # $ !&FF F ! !F 5 !
4 + +
% + + % % & ' ( ) !&FF
! 4 + +
? % ' 5$ % " = = < 7 J= B $ ! $ $ % $ %
$ %( B % B = 7 B $ !( B =5< ( > ++6 (
( ! ! - %$ 1
( ! ! - $
1 # ! ! ( ( & ( ">)$% ! *
( ++6 /& 466L4/
D 8 ? < " 8 %A # (
+ # , ++4 ) / % 8 & $ ++// *)&
+ ++ F /,. 4.4 $ ++// ! (
7 $B M ( A< 7 7B % 7 J ++4 $
$ ' & +++5 + + - % ++& 3,65 33+
( B' D B$ ? J 9 M " 9% 9 B ' A%
++6 > > 7 $ &$ ? $
- ( -,1& 625 /,
8 ? " ) " > % = " ++2
> 5( N 5 ! !
( " & = ! )))
* ( +& 34L 4.
? > ' '! $' '$ J J 9 A A * ) % ++4 '
5 ! ! (
& ! ! 5( * ( 2& /, 5/,/
A %> 7 ? J > 7 J ) < > % $ B%%
" BB 9 J $ < B '! ' DB (
B ++. O 5 +> !
- ./ 6/& 2.L6+.

134 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Cost Analysis of Early Stage ………….

7 ++6 & / , ./ " # M


P J % ' P % < = % < % > < P =5J % " <
$ J =5$ $ < % % ) P = ) J
K B % % J ! =5? B = B< ++, 5
O ( ! # (
! ! - %$1 .5Q ( ! ! - %$1& !
! ! ! 5 %$ *
( 3& +.L
8 ? % ' A A + + $ %$ %$
# 5! ( ( 3 - 1& 35 ,
J '" B M" $ 9$ A '7 < B ) M9 ) '% ' B 9 ++2 $ 5
% # ! 8 7 $ A & %$ %$ )
, 0 ++2 / -61& .235.24
% %% A 7 % % ' % % + + 7 $
$ ! < ! 5 ) ' * & - & &
4 .56+
J $ J7 ++. 7 $ ! B ( J<
& / / / // 1 " 9 8 M
$ " ? ' B ? " ? < J ' B ? 59 ?
' " ++. 5 ( '>>< (
) . - 6+1& 52
D = '> $ % 9$ 7 % ++4 $ ( (
$ ! ! % % # > 8 5 7 $ &%$ 5
> $ 5 % - ( ,& 2 .5266

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 135
M. Caecilia N. Setiawati H et al.

! " # $
% & ! # '( $ (& !# ) % & * '

! " # $ %

$ # & $ # $& $ # $& $ $


&& $' #( # $ $ ) ' $& ( $$# & $* $ $ #
$& $* $ ($ % $& $ $ + %
&$ # $ , + # $, $& # $ # $&
# $ $, # - , * $ # ',
# + # $ $ % # $& # *
% ( % $& # && + # $ . $ $ ,
$& $ ,$ $ # $ $& $ ,$ # $ % $* # / # && +
* #$ 0 1 $ , $
( &$ $* #$ $ # % # $ * , $& $ #
& $ + * &$ , $ # & $ # , $# $& (
2 , 3445+ $& $* #$ $ & 66 78 9
$ $& $# 6: 36 9 $ $& 6 67 9 $
$& # 68 67 9 $ $& ($ $ 6: ;5 9 $ $& $ #
;< 7< 9+ = $& &$ $ # & $ , $ , , # '
# * $ , , # && # + $& , & # && $& #
* # $& ( $$# $ ( # # +
, ' (&%#- $ # $ $ # & $ +

$ # & $ $ $ , $ $& # + 0 =
# 3443 63+< , $& *$ #* # # * &$ # +
0 # $& # # $, # $ # # $ > # $*
, $ & $ # $, $ +
$ # & $ # $& $ # $& $ $ &&
$' # ( # $ $ ) ' $& ( $$# & $* $ $ #
$& $* $ ($ % $& $ $ + %
&$ # $ , + ,, $' $ - $& $ # & $
? ? * $ , $ $ ,$ + % # $& #
&$ ($ # *$ *$ #* # + $ # $ ( $ #
# $ #$ @A1!B $ #$ , # $ ( $$# +
$ $& # % % ) C @1D) CB & $ # $,$

136 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Cost analysis and drug....................

+ # $, $& # $ # $& # $
$, # - , * $ # ', # +

>$ ,$ $ &$ ( , $& $ $ $&


) , 64)679 # $, # $ # , $ ;4)849 $ # $,
$ + $* # $ # $ ( , # $ ' $& $
@ B $ $ +> $ $ $( ( $ $
$ + $ ' , , $& $ , & , $& # # $ # $
&$ $* E) $& $ # F) ( $& , - $ , . $ $
$& $ , F) ( $& #$ $ - #F ) # $ #
($ $ $ $ , # * $ # ( $ # $
$ # $ + 1$ ($ $ $& # # ,
, ( ', #( + 1$ )$&) #
$ $ ( # $& # $ # # ' $ $ #
,$ ( #$ # & # * $( # #+ &$ $
,$ # - * # & $ + $ , $ )$&)
# # ($ # # # $ $ , & &$ $& # %
$ $ $ +> $ $,,$ $ $& $ #
&$ , * # $ $& $ $ #
$ , +

(" $& * , * $ # $ # $ # & $


# $ , . #$ 0 1 $ , , $# ( 2 , 3445
# $ . $ $ , $& $ ,$ $ #
$ $& $ ,$ # $ # $ $ % $* # / # && +
* #$ 0 1 $ , $
( &$ $* #$ $ / # % # $ * , $& $ #
& $ +

* &$ , $ # & $ # , $# $& ( 2


, 3445+

#. (&#
%& $ &$ $ $ %& $ &$ $ # & $ E

• > ( +$ $& , * # ( ,
• $( $ $% E, $8
• ( $$# , E $& , , $ +
• E - # , # % & $ 87 0$ -
# , # %& $ 77+ , * 8< # 7:
$# #& , * <G # GG $#+
• E $& , * #

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 137
M. Caecilia N. Setiawati H et al.

$& %& $ $# & ( $ % ( , #(


& + &$ ' , $ #* $* %
, $& + $ ) $# & ( %& $ # # '

+
@<< $ #B # , @GG $ #B * , $ $ #
# # & $ + # $ # #$ / $ # $ $ #
&& $& , $ $ # $ ( $ *$ +

(+ '
$ % & + $ 749 # 749 & +
( $& , * $$ @8 , B $ $ # / $$# $ $

&! & (
$& , $ # # $ # # $
# +
> $ $& , ( *
, $, 2 , # , ) , $ $ %$
, %$% $ + , $ $ , $ $ $ / , $ #
($ % # $& + , / ( $$# , $ # / $ #$* + $
, $% # $ ( * # $& ) , , ) , #
& '$ ) , # , , ) , + = , H $
, $% # $ ( * $ ) # # $
* % $* ( * $ ) , +

(# '# #
1$ * #$ $ % $* # $ $& / , + 1$ ,$ $&
# $ * # / $ $ / # $ $ # / , $
#$ $ / $ $ # $ # ($ $ $ + $ * #(
$# $ $ $& $ &$ +
$& # # $ $ #( $ ( 6+

&! (#
$6 ,, $, # #$ +
$3 $ #$ # $ @ $, #$ B+ >$ ;'G7 , # #
$# #$ G7 , # @ 3447 E ;G4<B+ 1 $, #$ G7
, # $ ($ && ( # &( $ $ ,$
@ " 344G E <63B+

$& $* #$ $ & 66 78 9
$ $& $# 6: 36 9 $ $& 6 67 9 $ $& #
68 67 9 $ $& ($ $ 6: ;5 9 # $ $& $ # ,
$ ;< 7< 9+

138 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences
Cost analysis and drug....................

= $& &$ $ # & $ , $ , , # $ #$ #


* $ , , # ( , # + $& , & # && $& #
* # $& ( $$# $ ( # #

/ 0 1 & (" 2 (34( (" 1 &'% ' % & 3 % (# (" 4 # ("


# &!3 (#4 3 &

1$ ,$ $ @ ,B 9 $ $

>$ $ / $ 646+;G; G7 66 78
I$# / $ 6<4+444 6: 36
/ $ 64+676 6 67
> / $ 638+;;6 68 67
I ($ $ / $ 6<6+<3: 7 6: ;5
$ # , / $ ;36+;85 37 ;< 7<
( 565 577$8 099

1 $( +H+ C % !+I+ C % + 1 0+1+ ! I+ + J K$ , I+I+ 344;


,$ $& K$ $ 1$ $
! E> , $& #
1$ * A+K+ 3444+ ! " # " +K % E A!1
A $ 3447+ $ %# + E $ $& +
K ! ($ K ,, # $ + @6556B+ ? % & $ &$ $ #
& $ 1$, E $% $ $ % , $( $
$ , $ # ( ,# # ( $$# , ?+ & 0: @;BE 35:2;4:+
I K+ 655G+ " ' ( "+ #( A + A#
+K % E A!1+
$ @3464B+ ? $ # & $ ?+ % % $ @67BE 67+ # 3464)4<)4:
($ K K ! ,, # $ + @65:5B+ ? % & $ &$ $ #
& $ 1$, + E # # $ # $ $ $ $ & $ +
1$, 1 # ?+ & 09 @64BE 5642<+
!+ 3447+ ) # * # ED $ % +
" + + # #" D+ 344G+ *( + ( , "+ "
- + A# H + K % + A ' # D$ , #$ D $ ,$% ! # +
$& ! C . % > & @65:GB+ ?1$ $ ,
( # % $& $ # & $ # ## # # ?+ .
& / 70; @38BE 67682:
" D D % D $ " = * @ , 3464B+ ?L $$
#$ ) & $ M? @ K , B+ . -- 0 ;5 @8BE <4G268+

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Sciences 139
Rini Noviyani et al.

! !
" ! # $! ! !
%
&! $ $! ! '
! ( % &! )*+'
! , ,% &! ! $ !
') )-. /)+' 0 $ ! $! ! $ -*. / 1)
0 - + , . / -,1 0 2 '. /'
0 -* 1+. / ,*1 0
%( $ , +. /1 0 3
, 1. /++ 0 **. / ) 0 , -+.
/ 1 0 4 % &! $ -- ,'.
/+ 0 , . / ' 0
%
&! ! $ ! !
$ ! % &!
$! ! % !
! ! 5 !
! " ! ! %
6 78& !

9 !
# ! ! $ %
!
! $ ! ! ! ! $
! /:! ! % , ,0%
$ $! ! !
! ! $ $ ! !
/;! ! ,,+0%
: < ! : ''-= ''2 1 ! $ !
! /78&0 -1%2. / >< 9 ,,+0% $
! $ ! ! ! !
/> : 0 -%1. / ,,*0%

140 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

7" ! /78&0 < !


% ! ! ! ! $ ! $
/ $ % ,,10% &! $! 78& !
% ! ! ?
@ / ,,10% &! $! !
! ! %
! ?A@ 8 ! ! !
$ ! ! ! ! !
/< % ,,20%
7" ! /78&0 < !
% ! ! ! ! $ ! $
/ $ % ,,10% &! $! 78& !
% ! ! ?
@ / ,,10% &! $! !
! ! %
! ?A@ 8 ! ! !
$ ! ! ! ! !
/< % ,,20%
! B !
/ 0 ! ! ! % &! ! !
! %>
! ! ! ! !
% ! !
! ! !
! $ !
" / >< 9 ,,20% !
/ ,,'0 ! $ ! ! ! !
! : ! ! ! !
$! ! ! 2% *. ! ! ! , *-.
= ! ,% 1.% 9 ! !
! $ "
! ! ! $! !
! = = % " !
$= $! ! $ ! $% &! !
! %
! ! B ! !
$! ! ! !
! !
% ! ! ! !
$! ! ! !
! ! " ! / >< 9 ,,20%
C ! ! !
! 78&
( ! ! ?: ! (
> 7 8 &! /78&0 ' ! ( ?$! ! $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 141
Rini Noviyani et al.

$ ! ! $ !
%

! " #$
! # ! !
$ ! '
&<& ! ( % &! $
, , $! ! $ $ ! 78& $!
! ( %

% " % % %%
9 ! ! ' &<&
! ( $ ! $ ! : !( / ! ? @
?C@0 $ ! 8 !( / ! ?;@ ?(@0 $ ! D
( / ! ?7@ ? @0 - ! 7 ( / ! ?E@ ?<@
? @0 $ ! )*+'
! % ! ! !
! ! $ 6

% 8 ( ( > 78& '


! (

! ! $ ! = =
! !
! ! $ 3 !
! % ! $ ! ! !
! = ! %

% > $ ; ! < ! ( >

142 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

&<& ( ; ' ! = ! !
! $ ! % !
! ! ! ! / 7 ,,10% &!
$ ! !
%D ! ! !
! %
! ! = !
! $ ! % &! !
$ ! &<& ! F ! %
< $
! ! !
/E ,,10% ! $ !
! ! ! !
% &! ! ! ! !
! F %
! ! = !
! 4 ! 4 !
" ! 4% / ,,10
$ ! !
! ! ! $
! % : &! / ''10
! $ ! % &!
! !
! % $! / ,,*0 ! "
# ! " !
! $ ! % 7"
! # ! ! $! $
" ! ! = !% ( !
" ! ! !
! %
! !
! % 7 ! !
! ! " !
$ %
> ! $ ! ! $ =
! = ! ! % 7"
! $ ! = ! $%

9G " *%) A
: % % %
9G A
: -% % %
" 8 : = ( /8: ( 0
$! 8: ( % C ! !
! = ! ! !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 143
Rini Noviyani et al.

! ! ! ! ! ! B = "
/;>A0 /H % ,,+0% " !
! / 7 ,,10% !
/D ,,+0% &!
" $ ! !
! !
%
= ! ! $ ) % 7"
! ! $%

9G ),, A
: -% % %
9G ( " A
: -% % %

8: ( ! ! =
% ! ! !
B = " ! ! !
/D ,,+0% ( " ! ! =
! $ ! !
/H % ,,+0% ; $ !
8: ( ! ! ! / ,,*0
! $ ! ! %
; ! ! ! $ !
+1+ % 7" !
! $%

9G ! " B ! : %
:- % % !

! ! " B ! / =
" B 0% : ! " B $ ! ! $
! ! %E ! ! ! %
; = " B $ ! ! $! ! ! !
! " B ! = B ! ! B
! ! ! !
! / 7 ,,10% ; = " B
/> 0 ! ! ! ! ! !
/ 7 ,,10% &! ! !
B D<> /: ,,,0 ! = " B
! " %
> ! $ ! ! - =
! = = = 4 %: = ! $
- % > ! <; B <;
$! ! ! < ! !

144 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

! ! ! < % & <; ! =


! ! ! !
! < ! % H B <;
= ! ! ! % &!
! !
! ! %
! < ! ! ! F
% $! "
! <; $! ! ! !
$! # ! ! ! B <;
/:3 < ,,+0% ! <
! 3 ! %
; = ! !
! $ ! ! - ! ! " ! $ 6

9G !
A
: % %
9G( " ,%*) A
: -% % %

! = !
" % H !
! $ ! ! ! <%
H ! /H ,,+0% ( " !
! ! ! $ ! !
! /H ,,+0% !
! " !
% D! ! ! /D
,,+0 ! ! ! " %
&! ! 4 ! $ ! ! -
! - ! % : $ ! : 4
! $ %

9 G /C !
( 0
:
:- !I
9G; B <; :
:- !

! ! ! ! $ ! = !
! $ ! B <; %
! ! ! ! ! !
< % (

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 145
Rini Noviyani et al.

! $! ! =
! /&3 9 ! 3 ,,*0% ! ! !
! ! !
! ! % ; B ! " ! =
! ! " B $ ! ! !
! /< ,,*0% &! $ = $ ! !
! !
! ! !
! $ ! ! =
! % C ! !
" ! / 7 ,,10% E
! /&3 9 ! 3 ,,*0% 8
! / ,,*0%
!
!
! ! !
! / 8 ,,,0 $! !
! ! /:3
( $ ,,+0% &! ! !
! % !
! ! %
! $ ! ! '*
/ 2%' .0 = ! = 4 = !
! %> = ! ! ! B <; $ !
$! ! ! ! ! !
$ ! ! % ; =
! $ ! ! !
B <; % ! $ ! ! !
= % 8: ( ! ! =
! ! ! !
! ! B = " /;>A0% ; B <; <
! $ ! ! $ B <; $
$ !! < ! !
/H ,,+0% ; 3
$ ! 8: ( ! / ,,*0
! ! ! $ ! !
%
> ! $ ! ! ! = 4
= " ! <; ! B <; %
! ! ! $! B ! !
! $! ! ! % ; ! !
2 ) % : $ ! !
$ %

146 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

9G/ ! !
! 0 A
:- %
9G " <; AJ
:- % %
9G ),, A
:- % %

! <; ! " <;


% < ! <; ! ! ! $
! /&3 9 ! 3 ,,*0% !
! ! ! $
! ! ! ! $
/D ,,'0% " !
/&3 9 ! 3 ,,*0% 8: ( 8=
= ! !
% !
! /: $
C ,,10% ! $ $ $ !
! $ ! /D ,,'0%
! $ ! ! $ ! =
! = 4 = ! ! %: $ !
= ! $ %

9G 9 A
: % %
9G <;H
<;H

<C %%
: - % %;
9G , A
:- % %

! = !
<C $! ! ! !
% ; $! ! ! !
! ! ! ! % ;
BB / 7 ,,10% ( <C
! $! ! ! $ ! !
! ! ! ! " ! ! ! " !
!% ( $
$! /:
< ,,+0% ! ! ! ! !
! % ;

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 147
Rini Noviyani et al.

! '* ! $! !
" $ ! $ %

9G "
AJ
:- % %
9G <;
! AJ
:- % %
9G " <; AJ
:- % %

7" ! " $ !
% &! ! $
! ! $ % &! !
$! ! $ ! =
" " ! %
" $ ! $ !
/ C 0 $! ! ! ! !
$ ! ! $ ! % &!
$!
! /H % ,,+0% &! " $ !
! B D<> /:
J ,,+K : ,,,0% ! $ !2 $ $ ! =
= 4 = ! ! %: $ !
= ! $ %

9G9
A
: % %
9G !
A
:- % %
9G
!
<;H
%
: - % %;%

: = ! ! ! $
$ ! %
! !
! ! !
! /H ,,+0% ! !
! ! ! !

148 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

! $ %: $ ! = !
$ %
9G " ! A
:- % %
9G; !

A
:- % %
9G " <; : %
: - % %;%

= ! $ " $ ! <; % C !
! !% E " $ ! $ !
# ! " $
$ !
/ ,,+0% " <; $ $ !
! ! /&3
9 ! 3 ,,*0% $ ! " !
! ! / ! ,,20 !
$ ! ! " % 7"
! ! $ %
9G; " J
:%
9 G /( =<C
!
<;
;& 0A
:%-
9G A
:% -

! " $! ! #
! ! !
/(8 0 ! B
/: $ C ,,10% ( <C $ !
" ! ! ! ! " ! /&3 9 ! 3
,,*0% <; ! $
! !
/D ,,'0% ;! !
= ! !
! ! ! %
$ !
! ! ! ! ! !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 149
Rini Noviyani et al.

$ ! ! " $ /&3 9 ! 3 ,,*0%


$ !
/ 0% &! , ! !
! %
! $ ! ! --)
/)%-1.0 $ ! = ! = 4 =
! ! % ! !
! ! % 7" ! % $ %

9G "
: %%
:- % % !
9( " G
/J C C C2

0 G
%% % % %A
:- %

! " ! $ ! $
! / C 0 $! ! ! !
! $ ! !
$ ! /H ,,+0% ( " ! $ !
! ! =
/ 7 ,,10% " ! ! B
! ! ! ! !
! /: $ $ ,,10% J C "
$! " C/ ,,'0%
! ! ! ! = !
= 4 = ! ! %: $ ! !
= ! $ %
9G9 A
: % % %
9 G /( =<C
<;H

0A
:- % %
9G/ <;
!
<;H

<C 0 :
: - % %;%

150 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

&! ! $!
$ !
! /: < ,,+0% C !
! ! $! !
! ! ! ! !
! = ! !
! % &! ! $ ! !
! ! " ! /H % ,,+0%
! !
! " !
%
> ! L1 = = 4
= ! ! %: $ ! = $ %
9 G /J C C2 C 0 ),,,
8 %
: % %
9G; B C ,,, A
:- % %
9 G / ><-
;
0
A
:- % %
9 G /J
C C C2
; = !
J
C J ;

; =
0
A
:- % %
! %J
C C2 C ! ! $
8 %E ! ! ! F
%< $ " " " "
C2 "
/&3 9 ! 3 ,,*0% &! ! ! !
" %

& ' ( ) & ) ' * )


> ! ! !
% ! ! $
! ! ! !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 151
Rini Noviyani et al.

3 % 3 $! ! !
=! % !
! ! ! !
! B % ! !
! ! /& ,, 0% 9 ! 8 B #! / ,,20
! $ $ !
% ! $ ! ! ! $6

-% : ( > > ( &<& '


! (

! $ ! $ ! ! !

& % ! ( > &<& !


' ! (
( H ! 7 :!
:
; " = C E C ;

; " = ;! 9
9
"
"
= 8
&! ! !
&! !
!
B ! = B !
&! ! B ;M
+), - + $! ! " ! !
&! !

= +
; -

152 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

= ;! (
; " $! !
; "
=> " ;! ( -
$! !
> "
7 ! = 7 ! 1
&
&
&
= ( -
;! B " ! B "
!
;! B "

; 8 = ( "
! !

= (

9 = ;! 8: ( 8: ( 2
!
!
9 = ;! 8: ( 8: ( -'
( !
!
! = ( 2
( " !
/ $
! 0
! = (
& !
/ $
! 0
! = ( -
! !
/ $
! 0
7 ! =
! ! !
"
!
B = ( ( -

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 153
Rini Noviyani et al.

9 B B

$ !

! !
B = 8 $ +
!

" !
9 = 8 $ 7
( B C C B B

C B B %
!
!
!
C B B
( B = > B (
> B ! I
"

B B C B B
7 ! = 7 ! ( 1)
( " ! !
" ! " !
!
=( B ( -

( B !
( B

!
! ! ! %> ! ! !
! ! %7 ! ! !
! ! # = !
! ! $
%:
! $! ! ! F / % ,,-0% &!
! # $ !
%

154 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

: ! ! !
$ ! !
3
! ! ! !
$ / % ,,-0% &! ! !
! ! ! !
! ! !
%

) (' + & ) ' (' *& ' ( )


! ! ! -*2 /+,%2 .0% !

)) ! %< !

+% E ' ! ; !
(

$ + ! %
: $ ! $ 6
9G:
! ),

/ !
& 0 G

G-
( " I
%% % % %A
:- % %
9G " <;
: % %%
:- % % !

! " ! !
$! ! %: ! !
$! ! ! = ! %C = ! B ! !

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 155
Rini Noviyani et al.

/J ! '')0%
; ! ! !
! ! ! ! !
! ! ! % C
! ! !
! $! !
%
; " !
! ! ! ! !
! % ! ! +,. ! ! ! ! !
# " ! / ,,'0% C ! " !
! ! !
%
$= ' !
% 7" ! $=
6
9G B !
! :
H:% %
)
9G "
<; 2,
4
!
<; ,
G)

G-
9G C ! " <; G-
%% % %
% AJ
:- % %

: $= $ ! ! !
! ! ! !
! ! ! $ / ,,10%
9 " ! ! !
" <; $= 2, $ ! , / "
0 ! ! / ,,10% &!
$= ! !
! B !
% ! ! ! $
$ ! !
" % H % / ,,+0 B
! ! ! ! !
$= # !

156 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

! ! % ! ! $=
" ! <;
/ " 0 ! ! / ,,10%
! / ,,'0 ! $ !
! ! ! ! : ! ! !
! $! ! ! 2% *.
! ! ! , *-. = ! ,% 1.% !
! ! ! !
-%,2. ! $= %'-.%
$= ! !
$ ! !
! " /< % ,,20% ! !
! ! ! % !
B ! ! $ ! ! B !
! ! ! ! ! ! 3
! ! ! !
%
! ! !
! %> ! $ ! "
! %<
$ ! ! ! '
! ( %

& % ! $ ! E 9 (
; ! ! ( '
;
(
! ;

&!
; =
>! 3
4

9G 7 :
;
& & & & & &
& & & &

' ) , +1+ , ) , , ,
- - -, - +'' , ) , , -

+ * + )' 2 ) + + , , ' -

) +, 21 '* , ) ' ) ++
'

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 157
Rini Noviyani et al.

2 +1 +* * - ) +) ) ,, ,
'
* ' , 1 -+ ' + - 11 -
2 +
1 2 ) +' , 1 +2 +

' , -, ) , * , 2 1
2
, -2 -' -- , ) - -- -
2
+2 - , 2 +2
*
, ' 1 ' , , + + ,
- , 2 - , , - ,
+ , , - , , , , ,
) , - ) , , , - ,
2 , , , , , , , , ,
* , , - , , , , , ,
1 , , - , , , , ,
' , , , , , , ,
, , , , , , , , ,
, , , , , , , ,
& 1 - ' ,*' 1 ++ ) 1 + '
) ,2

! ! ! ! $ !
= %( ! $ !
" ! = ! = =
= 4 # % !
! $ ! 3
% &! ! $ ! ! ! %
$= !
- ! !
! ! ! ! !
% !
$= $! !
$ ! % !
!
! /: , 0% C !
! ! ! ! !
% & ! !
3 ! ! !
! ! $ ! ! %
&! ! !
! ! ! ! ! % ! !

158 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

! $ ! $
! # ! ! / >< 9 ,,'0% D ! !
! " ! ! $ ! %
9 ! ! ! ! !
! / (90 !
! $ ! !
! ! /;! H ,,20%

" %
% ! ! ' &<& (
')%)-. /)+' ! 0$ ! ! !
! 6 $ /'%+2.0 - / +%**.0 + / 2%12.0 ) /'% ).0 2
/ -%*2.0 * /)%-1.0 1 /)%2'.0 ! 1 / *%21.0 $ !
= -%-*. + %, . = = 2% '. -*%1+.
= ! / %0%
% ( ! ! ' &<& (
+%,). ! $ ! 3
,% +. ,%1. %** . 4
,%-+.%
% ! ! ' &<&
( ! =
--%,'. /+ ! 0 $=
,% . / ' ! 0%

,, %
% ,,*% ! % / , ,8 +0% 6
! 6GG % % % G G -+)2*1'G* *G G,17,, 1%
% ,,,% % ( 6 H
%
! % ,,'% / ,
10 6! 6GG$$$% % G G ! %
% ,,*% % 6 &! E
H %
% , % / , 0
6!
6GG$$$% % G G N O P O
P O-1 ' ,P O ! 4E 4: P O)+,+)P
O; !4: 4> P ! O-1 )-'
% , % %; % 6 ! 6GG$$$% %
<% ;% ,,1% ! " # % ++= '1% 6 %
% % :3 % ,,+% $ " # " % &
6: E% E $ % 6
% ;% % & % % ,,-% # & % ,% 6E %
8% ,,'% ' "# " " "& "
( ( )**+ % / , , *0% 6
! 6GG$$$% % % % % G) )-G G ,,,), +'%

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 159
Rini Noviyani et al.

C ! 9% H% 7% C% &% D% : % ;% % 8% : % ,,1%
! 6 C % , - ,,16 - / 0 -1-=
-1' / , ,( )0% 6 $$$% % G % ! N (O ',2
;! % % :% %7 % ,,2% # &" % 2*= 21% 6
7E;%
;! ! 9% 9% ,,+% 9 ( % ( # . ),6 ' ='+ /
, ,( ,0% 6 ! 6GG % % G3 !G ,+G G3 ! ,+ ' %
;! :% % 8% 9 ! H% M% % H% : :% J % ,,2% 9 !
&! ! ! & ! 6 & ! !
! -)6 +)* / , , > *0% 6
! 6GG$$$% % % %
;! 7% ; H% ; 9 % ,,2% &! !
$ ! ! % : K +/-06 ,-= ,'%
( ! % :% ,,'% ! % 2% 6 :
%
< ! 9 % ,,+% , "/0 -
& / 12 / , , 8 +0% 6
! 6GG , %*,% -2%'*G "% ! N O $ P O $ P O*,,P O
< ! 9 % ,,2% & " ! %* / , ,8
+0% 6 ! 6GG ! % % G , ,G,-G = =
= = = %
< ! 9 % ,,'% ", 0 34 )**5
" ' & % 6( ! 9 %
7 % ,,2% ! # ,!7 %: 6 E $<
% :% (% H% (% H% H 7% C $ :% H% < % H% %H B %
,,1% 6 7 , 8: ! 7 0 : 6 &! E $=<
;
9%: 3 $ % % % Q% % ,,1% &! ( > 8
:B ; "= ! & ; D !; & %7
8 &! ( < / ,
10 6 ! 6GG % ! % % G3 G ! $ G ,,1RJ R G =
+%
E (% % ,,2% 7 ! 9 ( ''6 *'*=1,, / , , 8 +0%
6 #3 % " 3 %
E % ,,1% - : % % 0
/ , -0% 6
! 6GG$$$%$! % G R G G G G R8 $: R78&%

< 3 E% :% % B % '' ( <


! , ( ,, 6 )= '
< 9% :% : % ,,2% < (
9 > > ( $ ( 3 :
> /: ?A@ & 0 ' , & 6 22=**
/ , 0% 63 % % % %

160 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Irrationality in oral drug...........................

< % S% % ,,*% " ; & " "


"% ( " %8 % J , = ,,*
< % D 9H S ; ( ; H9 % '' % ;! !
! 7 ! ! & $ !
; 7 ! % '' : K) /-06 - =1%
H ;% % H% H% % %E H% H% H % ,,+% < , 6 "
4) % >! 6 H " = %
H 9% , ,% , < = ! % 2 / , , ( )0% 6
! 6GG$$$% % G R R R R
9% (% E% H% 8% ( :% :! % ,,,% : $ ! ? T @
! 6 T % ! (
! K- ,6 1+U*%
! % % S H% (% : % % : % ,,*% <
, 6 ; / , +0% 6
! 6GG$$$% ! % ,) )*= 2 =
! % ,,2% % 6&! E
H %
8% % ,,1% ! 6& 7 < ; ( !( ,,16 / 0 2='
/ , *0% 6
! 6GG$$$% 3 % G G ,,1G 3 ,',1 %
7 E% % ,,1% 6# < , : 6 6
,
% % ,,,% " ! "
/ , 20% 6 ! 6GG$$$% % G : >
>)*44>*)>? 45@ A@3
(% ,,1% , & 6 " ! % =) C C 6
C %
&% ,,2% ! " ! % / , , > )0% 6
! 6GG$$$% %
8 B % % 8% % #! ,,2% %- " < ,
, - = 8, =B 6
! 9 ! / ,,20 -6 )= 1 / , 0% 6
! 6GG$$$% 3 = % G( G ,, G 9+ -%
$ D% % % D C% : % ,,1% : C D
( $ &<&% ( =,, -*=-1 / , , 8 +0%
63 % % % G "G ! G: G G $ G* 'G21-%
9 % ,,*% 7"
) /*061)'=2)%
: <% :% >% <% 9 % ,,+% " # "
% & 6: E% E $ % 6
: :% :% % ,, % < & ! % ) 6
;J% : : %
: 9% , < " / , 10
6 ! 6GG -= % G -G$ = G G , G,-G !=
= = = = = %

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 161
Rini Noviyani et al.

: 9 J% <% :% E % ,,+% % # "


% & 6: E% E $ % 6
:! ! :% ;% <% % 3$ % % % J% C % , ,% ( < B
9 ( 6 9 $% ( % 6 ,2= / , , ( ,0%
6 $$$%3 %
: % (% % 7% 9% ,,+% < - , 64 %87 8 $
7 -) 6 ,-= *
: ;% % % ,,1% " # < " ! % + *% 6
7E;%
: $ C% : 3 % ,,1% & )% : 6 !
+%
:3 <% 9% ( $ % ,,+% 6 # "
% & 6: E% E $ % 6
: (% % % &! % ''1% & 9! 6 7 =C
7 8 ; J 8 ! ( ''1
+6 1'='2 / , *0%
6! 6GG$$$% 3 % G G G ; ''1 : 1'R'2%
: % ,,)% " 7 < , ! % H 6 &! ! %
: % ,,2% " " %C 6 ;J% %
:$ :% ;% ,, % < % ! =! %H 6
!
& (% :% ,, % < , # ! % )% ; 6 D $ ; %
&3 &% <% % 9 ! 3 % ,,*% % 6 &% E
J ! 9% '')% ! " ' " # 7 )% M 6 E %< ++
D % 9% 8% ;% : % C% D 7% M% : % % : 3 % 9%
: % '' % # " " "% M 6 E 3 !
%
D C E% % &% ( &% H% : !$ ! ; J% ( % ,,'% ! ! <
: !7 % : 6 &! E $=< ;
D<>% '1)% = < %C - /
, ,8 -0% 6 ! 6GG$$$% %$! % G
D<>% ,, % = D ! % / , ,8
-0% 6 ! 6GG$$$% %$! % G
D<>% , ,% 6 : , - < = 6 # ! % , / , , ( 0%
6 ! %$! % G
D H% D % ,,)% 0 7 < ! %-/ , ,> '0%
6 ! 6GG$$$% $ $ % %%%( R; !R&! R ( %
D % % ,,+% " " " 0
# " % & 6 : E% E $ % 6

D % ,,'% D " . " ! % / , ,8 -0% 6


! 6GG$$$% , !; ! %

162 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Rini Noviyani et al.

!
" # $#
$
# % " & '
& # $
( # #
!" " ) )'
& # # (')*+ , ( -$ #
./0 # ()' 1+ , 2) - 3 24' 1+ ,*(
-$ 3 5 6')(+ ,21 -$ 3 ('76+ , 7
-$ 3 )'7(+ , -8 , 9 - )'7(+ ,
-8 : , 3 - 4' 6+ ,22 -8
# 7$)*+ ,4 - 2'61+ ,2) -$
9 )' 6+ , -' " #
; 67'* + , 62 - < 4' 6+ ,22 -'
& # % "
& # 1*'(1+ , -'
$ $ $

! "# !
#
4
'" $ # 3 :
24
'& #
' #
3 /2+ $ # 4+
$ )+ $
2(
(4+ # '
= '
*
>9 ' $ # 6'6+ ,4) -'
,44'(+- # $
9 , '6+-$ , )'(+-$ 3 9 ,*'7+-$ : , '7+-$
, '7+-$ , '6+-$ ,)' +-' %
#

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 163
Study of antibiotic use in.....................

, '6+-$ , '(+-$ , )'*+-$


, '( +-'
/ ?
@ ))1$ #
'
$ # 3

1
'
$ A
" , " - $ ;$ <$ "$ !'
&
# '<
7
$ ;$ < $# " ! '
22
B $ " '(4+ # $
2)
# @ ! # 7'77+'
# " !
# '

'
# $

# $
$ 3
$ 3 $
7(
: '
;
!" $
# C !
" '

$! !%!&'
&
$ #
, "&-
# ' $ $ 3
'&
# #
' B
) ) " ) ) C !"
# '

"% #" !
C $ #
#
"&' B (

164 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Rini Noviyani et al.

477 # B # C
D !" ' $ ('*)+ , (5 277
- # # #
'

( ) * * ( + ) *

'&

$ 7
# ./ $ : $ $ '
./ # ()' 1+ , 2)5 ( -$ #
# )'7(+ , 5 ( -' & ./
3 #

(
# '

'&
$ 3 $ 3 5 $
$ $ 9 $ 3 $ $ 9 '
3 # 24' 1+ ,*(5 ( -' 3 ./
'
$ 3 $
7
/ # '
)
' # 3

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 165
Study of antibiotic use in.....................

< #
# 9 '

( ) * * ( , ) - ). ,
=
, $ $ -$ , -$
, < $ $ $ -'
" & '

& ' ; " "

& $ E #
4 '64+ , 5 ( - 2 '17+ ,(15 ( -
1'77+ ,7 5 ( -' B #

'&
, -$ 9 $ $ $
7
# # # '
$ ./ #
# 4 '21+ , 5 ( -
, 3 $ 5 - 77'77+ ,1(5 ( -
, $ - ('17+ , 45 ( -' ./ $ 3
, - ('64+ ,465 ( -
$ #
D , -$ 9 , - $
3 , -' 3
/ / $
6
'

166 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Rini Noviyani et al.

# $
2'

2'

2$ #
# , -' $
'
#
7'

7' &

7$
' 3 # '4+ , *5 ( -
'=
$ ' 9
'
# $ # 9
# #
2 $ 7
'

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 167
Study of antibiotic use in.....................

F # # A $
$ $ #
#
'

" ) * , ) # , ) * /
# " , "
-$ G $
;$ <$ "$ 3 7' $
4'

4' "
4$ ; <'
$ "$ ! 'F # $
; < ; #
< 7' & #
" '
< ; # 67'* + , 625 ( - 3 $
3 5 $ $ $ 9 $ $ 9 '
< 3 4' 6+ ,225 ( -' & 3
7$ 7
,: - # E ';
4
0 # 3
# #
'
#
$ ('

168 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Rini Noviyani et al.

(' ; <

($ ; <
'< ; 2('4*+ ,*1 62 ;-
'< < ('17+ , 4 22
<- '
$
'

*+ & , * ( .
$
#
'&
*'

*'

*$ # 1*'(1+
# # $

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 169
Study of antibiotic use in.....................

# '2 +' ; $
4 #
& '

& ' @ # "&


& + )
- ( ) 0 ,
,
, ( ( . )
%
; D 3 $
$>
& 3 5 9

2 ; 3 < $
H 9
7 D < 3 3 $
3 5
$>

& $
, $ - , $ -'
$ '
F # $ #
3 $ $ ' 3
,2/ '
# #
/ , ; / A -
# $
7
# , - I 'D
./ '
$ ./
'<
$
$26
D ' & $
#
# $
2
3 $ '
$
3 3 5
'F # $
9 ' 9 #
"@ ' $ 9 #
"@ "@ 3 "@ '& #
$ 7
' $
3 3 5

170 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Rini Noviyani et al.

' ; < " < ,<"<-( 9


$ # 9
1)+ /14+' 9
$ #
' 9
# $ $ ; '2 < /
4
' # 9 3
#
9 '
$ 3
'
9 ' $
, -' $
9 $ 9
' # $ # 9
6
$# 9 '
(
,<"<-
$ / '
<"<$ *6+ / 67+ #
# 9 $6 + $ *4+ # 9
' C # $ 9
' # #
9 $ # 9 ';
1 6
9 $ # I ' < #
$ # 4) D
$ #
$ 7
'
$
3 'F # $
3 $ 3 5 '
" 3 #
' # $

# , ;-77$ '
7
: ' < 3
7 7
: $ E I '
4
0 '
3 $ 3 <
'
= $ 3
# #
#
# '
$
# 'C # $ 3

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 171
Study of antibiotic use in.....................

# C !" '

#! #%" !
' # "
C ! " ) ) # ()' 1+ ./ ,24' 1+ 3 $
3 5 6')(+$ )'7(+ $ ('76+-$
, 9 - )'7(+8 : , 3 - 4' 6+ 7')*+
, 2'61+$ )' 6+ 9 -'
' &
" C = ! "
" ) ) 67'* + 4' 6+ ; <'
2' 1*'(1+ C
= ! " " ) ) #

'

/ #
9$ %' ))6' '
' / *'
$ '$ <' ' & $ ' ' ))2' ' G &' > 3
' ' *1/ 6)'
; $ '& $ =' $ &' B' > $ %' ' 114' D 9
G / ' ! "# $ % & H ' * , -G
4 4/4 1'
; = B ' ))6' ' "# ' ' G = >B = <H D
D ' ' 24 /7 1$ )4/ 4 $ 6 / 62'
< / $ &'$ ' < E $ ' $ 0' C' / $ ' ' B : E $ >' B' '
9 & J / '( ' H ' 77G *1/ 6 '
< " < ,<"<-' 116' % ) * +
) ' G 'D' " C C D ' ' *)/*7'
< $ ' "'$ ' D $ ' ' F ' ))4' , ' D G < < D
'
< /; $ ' ' ))6' ? &@ #K G % #/C
" '
< $ ' D'$ ' ' < $ 'B 8 B' ' ; $ <' ' C $ "' ' C ' ))1'
" B ; " G@ ; "
D '! $! , ' (2, -G 1*6/164'
< $ ;' ' ))7' ! # - ' G '
" $ ' C' ' C' H ' ))7' "# . / $> H' G >%<'
" B ' ))(' "# ( # ( # ) # ' G"
B ' ' 6'
" B ' ))*' # ' G"
B'

172 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
Rini Noviyani et al.

" ; ' ))4'


' * & G" B ' ' 6/ '
" ; ' ))(' . '#
0 , ' G" B ' ' $ 6$ 22/2($ 26/
76'
" $ F' '@' )) ' ' G >%<'
>9 $ ' '$ ' >' > $ ' <' = $ >' ' > ' ))*'
# ' ' 4,2-G 24/ 21'
% $ ' '$ D' ' $ ' $ 'C $ ' ' $ <' F ' )) ' D
; H '! , ' H ' )G ( /* '
C E $ ' ) )' 0 ' ' 'K G ' ' 4*/46'
$ '$ >' < $ ' $ ' ' ' )) ' B 9 & 9
3 & ' '
"# $% ' 1G 1*/ ) '
9 $ ;' %'$ ))7' $> 2' GD '
' )))' ) ' " G B D
D '
' ))1' ! # $> '" GB D
D ' ' 2/7'
0 $ <' '$ 0' 0' $ ' '% $ 0' 0' 0 ' ))(' ' 0 # $
7 > 'C G 0 3 /< '
0 $ B'$ ' $ >' C $ B' $ D' D $ ' >' " $ ;' D ' )))'
= # % >3 : G
< D '! * , # ' H ' 7 G 22(/ 221'
$ ' >'$ ' D' " # $ ' ' C $ ' B' $ B' D' $ C' ' @ $ ' %'
$ >' >' B $ ' F' %' & ' ))6' ) % ' G &%
'
$ ' ))1' ( $ 4* > ' 0 G ; % B D
'
$ ' ))(' > $" $ H ' , / $
1 2 0 ' H ' 4 ,(-G 7 2/72)'
@ $ "' ;' %' ' )) ' ; H G<
" '- / ' 7G ) / )6'
@ $ "' ))1' - "# '# 0 "#
% *. &, / * ) 3445 , -' D G
D '
@ $ C' ))6' ' $ ' G" @ '
= $ @'$ ' ' % $ ' >' C ' ))4' ( 6
) G D B #' ) ! "#
% ' H ' )4 ,7-G 64*/6(6'
B $ 'H' ))1' - "# '# 0 /
* . , * ( , 3447 , -' D G
D '
D E $ B' ))4' "# ( ' , -$ , ) )$ @ $ )-&
G G55###' '# ' ' '

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 173
Study of antibiotic use in.....................

D $ B' ) )' '


*7' H ' 2* , -G / ('
D $ C' ' <' @' ' )))' " ' "# $
% ' )G 77/4 '
D $ ;' ' ))6' ' , -$ , ) )$ " $ 4-&
G G55 ' '# ' 5 ))65)45 / /
)*6 7)11'
D # D E $ ;' ))6' , 3' D G '
' )/ 2)'
D $ F' '$ ' < $ ;' ' < $ ' %' ' " $ ' ' $ D' ' % $ '
' % 9 ' ))2' ) % ! # 6 83' @ G&
% 0 '
D $ @' ))1' ( * , #
'" GB D D C '
D $ >' K'$ B' E $ ' 'D $ ' ' $ ' ' 'D $ ' ))6' '*"
' G &' D ' C ' ** /**7'
& $ ' )) ' / ' GF ' ' 72'
&E $ &' C' ' B E ' ))*' "# "# 9 9 -
* ' G &' > 3 ' ' *4/*($ *6/*1'
FC=' )) ' 10" , # ' G . ( ' &% G
F C = 9 '
FC=' ))2' ' . : '% GF C = 9 '
F $ @' ' ))1' ! # ' *
( *. & * ) 3445 , -'
D G " D '

174 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
'5
' 5 ( #%
' " )

! < = $
" #$ # < > #%
% &$
' ( ) * %
) ) * +!
" ! 48 $
, $
- $
) ) %
) . ', - %
) &$
/ - $+
/0 1 $% , - ) %
2 , 9
, %
, 9 &$
3 ) * +! , - )

- 4 !
/, 9
,, %
56 * 0 , *
5 *) #% /, 9
4 2

7 /0 6 /
7 8 $%
7* +! 6 2
7 *, %
7 * &!
= < %

" 5
" #$ # * ' 06
" +! , /
" 9 * /
. !
' * $%
: 0
: / %
: $ )< $
: / &! )
: / 2 06 ) 0 %
) &$

( +!
/ ; / % 1 $+

' 06 ? 6 #$ # % &!
' 0 !
': , * !
' 06 &$ @ " $+

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 175
0 /1 0 !
0 - * /* $%

0) $
&!

8 4 %

176 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
7
7

: ; " (

< "
<6=2

!
"
>
#
>
" >
$% &' >
(#

! )
* ) =
= )

+ !
+ -
+ - " #
+ - "
+ # - "
+ # - "
+ , - .+,-/ # - "
+ - #
+ ( - ! !
+ 0 - (#
+ -
+ -
- ! ! $ .- ,</
- ) )
1 "
1
123 ? ""

4 , "

5 (# '
' #
' #
6 " ' (#
6 # '
6 $ #
6 #
6 3 )
6 ""
6789 7+' ""
@
@6=? <! ,14 ""

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 177
"! # " " $ %# & " ! ! # % ' ( !!)
* * ( % # ! % % * " +& % & "
& " " $ , !! * + $' - % * " % ," ,!-
' - % . ," * -!" $ " $' %# & " - ! " # ( !!
/ * + ,! " # ( !! %#! % # % ' "- )
' " + -# " - # % ' -" ", ! ! # % ' * #- * "
' & % # $! ' " % & * % . % %# +
-!" $ % %$ " * " ** ! !# % '
0 ', ! %# 1 ! '2 # # 1 # !2 * ## & " +)
. - + + -" ' " -"' ! - " ' * !! # ' # %
# #

3 44 .
$ , , # # 5 ", $ + -$5 )
. ' * !! ( * $ - ' % 1 ' %- 2
/ * , %- ' % )
, % # # $ - % $ !6 " " "- " $ - * ( " , " -+ , "
* !! ! % % " , ' ( + % "
0 * -!" * ( * * ,, " % %- )
" ,, -! , * * , % - # ' ! ##
7 % - " %- )
!% %- $ - " $' % + , , 8 %#! ,!- , %
& % % + - " % %-

9 . # 9
. * !- - " , - -% - !& " % + " " *
" ,, * ' - # 5 -!" ' - 8#! $ - )
. " ,, " - -% '- : +;" ' "" * -++
- < %+;(+;* +
/ # & % $ ! )
- =7 # * "&" " / + -# " " ,, $ ! " !!
-$5

! "

4 4
* $ - % - ! # !! - )
! -+ %#- 6 " " & ! # + % - ! # !! - "
/ * $ - " & ! #% , ># $ + %%- ' # % ')
9 & ! #% , %%- ' # % ! ' * ># $ + !! " ! + %
0 *" ' -% , ? ' %# $! % ! . )
% %# - " * % ( # # %- $ + & , 8 %#! ! -% # #"
%- $ % 8 " " ,# # $- - - !!' %#- 6 " * !! + & % !

9 3 9 4
*" ' -, !! + )
$ - * ' - # "- +& $ , ! " ( + 5- % $ +
# "- * (* + "- ! " & ! #+ % " " % %# +
* +* ' - "
/ ! # % ' %# ')

178 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
" ( *! "+ $ - % " ! #!- ! % " " - " " " * * -! - , 8 %#!
$ # # , " -##! %

@
'% ( + +' $ " " !* " )
$ ,* & ! - * %# & - !% "

"
% ! 4 " + 5- + 6( " 5 '
$%&'()*+ ( " ! % "" ' -- , ' - # % )
+',&- . % " %' # & -"' + " , %% " ", % # !
% # * "- ' , + " !' * ! - - @! $ ! ,
# % , * #- " ! , - , ! , # % - !
* ( " " !- -!

$%&'()*+ - - " -+ ! # $! % * ' ' - " " ? - " -+ ! " # $! % ")


+',&- 9 -+ ! # $! % # , " -+ ! " # $! % , %' $ - " -+
! "
# $! % # ! # "# # !' ! * ( * $ - % % "
- % $- , & 5- * , - " -+ ! # $! % - % $ - , -
" -+ ! " # $! % ( ? $+ " " $ - <::: , & 5- * , - , " -+
! # $! %

$%&'()*+ ' ' - "" ? - " -+ ! " # $! % ' " ,, $ * " -+ ! " # $! % "
" -+ ! # $! %)
+',&- . " ,, $ * " -+ ! " # $! % " " -+ ! # $! % " -+ ! # $! %
# $! % * * , % $- " -+ ! " # $! % % ! + $ - " -+
" -+ ! ! " -+

$%&'()*+ -- % " ! # , % * "" ' - , " - ! # $! % * *


" ,, ) *' - - ! # $! %)
+',&- , ' - 5- !( $ - " -+ ! # $! % !! # $! % - ! $- * " ? ( * $ - -
% $ - ## $ - ! # $! % * ( * # $! % -
+- " ! @ +- " ! 9 -+ ! " # $! % " ,, * ! # $! % , * * ( * " -+
! "# $! % - ! # !* & ( * $ - * # $! % ## "* # $! %
## * * * ( * ## 8 % " -+ - ! # !

$%&'()*+ , " , "# * ' ' - 5- ' , " # # !)


+',&- - %' * ( * $ - * %$ * " ! "*
## # ! * , - %' , # ! %' " +& , % ,
# ! ( * $ - '! , %

"

!
4 '- 6 * !-" +. -

$%&'()*+# ' - # * - % ( # & # # # % ' , !


# &" )
+',&-# !' $ %# " ! # % ' ! ' ! ' % " $ !'
! * $ " . , , - * " * ( #, % ' , ! * " - + $ -
# ,# % ' * !" ! ! - " " " " , ! * " " - + # !
" - + -$ 9 $' - !, $ + " + A- ! ' # % "( * * * " ,
!# # #!

$%&'()*+ % ! ' 1* 2 +& -! " " -+ , % ', , %)


1" 'B + C # 2)

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 179
+',&-# . , , # % * " !' # , + $' $ !' + ! +
% % !< ++ % ! ' *+ "' - * !! $ # ' " $ - ' - # , !

"
.
" % ' % ' ! %# -( @ -+

$%&'()*+# ' +-! $ - *# % ' $! % $' ># % )


+',&-# . +-! & - ! *

$%&'()*+# * $ - # # " -+ * # % " " " !" * # # "


% + 8# "" * + + ! )
+',&-# . # % - - !!' + , % " #!' " +& % - ! + " -
# ? " * !! $

/ 0
" '- ! " &' D ' @" " " (

$%&'()*+# " " 5-"+ 9 -"' )


+',&-# D % 9 - # + " " " - % ' " " % ( 5-"+ % *
#- ' $ - +& ,

$%&'()*+# * ( * " ,- ' #' " ", "" ! " -+ * $ "


%%- '# % ' "% - , # & -"' )
+',&-# "" ? & % " ! " * 5- & # # !( A- , % * - ( #
( ** ' #' , #

$%&'()*+# - % " ! " * -!" ' - ( * * !" * # ) * ' - " , "


9 ?
+',&-# 5- & # # !( A- , % * - ( # ( * , % $ - #

! " !
1 2
! * % + > + ( -6 '

$%&'()*+# ' , " -+ 8# & E:F , % ), %" >" -+ %


+',&-# " -+ % , -% $! + " -+ ! ( 5 & ! , # *
" & - - !!' 8'+ , - % + " -+

$%&'()*+# ' # + ,# # ' " -+ % + + " -+)


+',&-# $ - # # '" -+ # ! % ( + & % # !
+ & % " , " -+ " " - - !!' $ " " " -+ $ -
"- ! # % ' +& # ! + % * ! " !( + " -+ "
# + # # ' " -+ % + + " -+

$%&'()*+# - !' - 7# !' " ' - 8#! * $ - (, !' ' - '


$ - " $ '#
+',&-# . !' 7 # - !!' # #! " # * /::E
% :: # ' /::E * !% " % $ - # & 0
% ? !' 7 # ? " & , % $ - % :: # ' * 8# "
? -!" $ % E G # * + # % /< # %

$%&'()*+# - !! % * (, , % -! , " ' %# (, , % !


", % # "
+',&-# (, , % ' - ! 5- !( , % " $ # ( % ' ? $ $- '
% ( " !! , % & '#

180 The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science
$%&'()*+# * ( $ - , " -+ $ - % , ' - # + # ! +' !
" - '# -## ' - !- , " -+ !-" + '# " -+
!' ' " -+
+',&- . , " -+ !! , " -+ " , " # ! ' " -+ !! , " -+ , - !' !!
# " ? & ' # !" !' # -%$ / + , 8 $ - ! +
" " -+ !( '# , # , ( ? !-" " " -+ ! (
!# 6 ! % " % # 6 ! , % ", % + !! !! , " -+

$%&'()*+# ' - # # ,! * " ' - 5-"+ % 5-


9" ' - - ' # !% " ' - 5- (, ! A- )
+',&-
$ - # ,! & #!% " 5- % ( & ** # ! A-
$- # A- % ( & * # " !! , % " '* $ -
* ( * , % , + % $ - " , % ' ' ( %# & % ,
! !! , ' # !% " ! ( - + A-

!
#
% 5 ( % * @ -+ -

$%&'()*+# " ' - %% " -!" ' - + & * '' - %% " "
$ - # % # , % * "% " , % )
+',&-# - -! * -!" + & , % $ - " -+ , % & $ - # % ,, 5-
-!" " "% + , '* + & " -+ , % " -# & $' # %

H -! D D % D %> ! # . + !

$%&'()*+# -!" ' - 8#! $ - 8 ' ,- + $ )


+',&-# . ! $ ' " " '%# % * $ - 8 ' %+ $ 8 ' * -
!!'

$%&'()*+# $ % 8 )
+',&-# . " # $ - % 8 $

( % * - # ! -( D "! -! %
4 (

$%&'()*+# * * % ( - " * !!' ( , % %#! # " )


+',&-# ' " + ' ( + & 1 $ + # " "- + & 2

$%&'()*+# " * !!* ", % # % * + 6 " %-! "# )


+',&-# " # " 1 5 2$ - , # % + 6 " " * & !"

The 2nd International Conference on Pharmacy and Advanced Pharmaceutical Science 181

Вам также может понравиться